<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Band ligation versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis - Cifuentes, LI - 2021 | Cochrane Library</title> <meta content="Band ligation versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis - Cifuentes, LI - 2021 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011561.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Band ligation versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis - Cifuentes, LI - 2021 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011561.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD011561.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Band ligation versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis" name="citation_title"/> <meta content="Lorena I Cifuentes" name="citation_author"/> <meta content="Escuela de Medicina, Pontificia Universidad Católica de Chile" name="citation_author_institution"/> <meta content="Daniela Gattini" name="citation_author"/> <meta content="Escuela de Medicina, Pontificia Universidad Católica de Chile" name="citation_author_institution"/> <meta content="Romina Torres-Robles" name="citation_author"/> <meta content="Pontificia Universidad Católica de Chile" name="citation_author_institution"/> <meta content="Juan Cristóbal Gana" name="citation_author"/> <meta content="Division of Paediatrics, Escuela de Medicina, Pontificia Universidad Católica de Chile" name="citation_author_institution"/> <meta content="jcgana@gmail.com" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="1" name="citation_issue"/> <meta content="10.1002/14651858.CD011561.pub2" name="citation_doi"/> <meta content="2021" name="citation_date"/> <meta content="2021/01/26" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011561.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011561.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011561.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Chronic Disease; Esophageal and Gastric Varices [*complications]; Feasibility Studies; Gastrointestinal Hemorrhage [epidemiology, etiology, *prevention &amp; control]; Ligation [adverse effects, *methods, mortality]; Liver Diseases [*complications]; *Portal Vein; Primary Prevention [methods]; Venous Thrombosis [*complications]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011561.pub2&amp;doi=10.1002/14651858.CD011561.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011561.pub2&amp;doi=10.1002/14651858.CD011561.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011561.pub2&amp;doi=10.1002/14651858.CD011561.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011561.pub2&amp;doi=10.1002/14651858.CD011561.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011561.pub2&amp;doi=10.1002/14651858.CD011561.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011561.pub2&amp;doi=10.1002/14651858.CD011561.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011561.pub2&amp;doi=10.1002/14651858.CD011561.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011561.pub2&amp;doi=10.1002/14651858.CD011561.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011561.pub2&amp;doi=10.1002/14651858.CD011561.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011561.pub2&amp;doi=10.1002/14651858.CD011561.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011561.pub2&amp;doi=10.1002/14651858.CD011561.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011561.pub2&amp;doi=10.1002/14651858.CD011561.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011561.pub2&amp;doi=10.1002/14651858.CD011561.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011561.pub2&amp;doi=10.1002/14651858.CD011561.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011561.pub2&amp;doi=10.1002/14651858.CD011561.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011561.pub2&amp;doi=10.1002/14651858.CD011561.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011561.pub2&amp;doi=10.1002/14651858.CD011561.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011561.pub2&amp;doi=10.1002/14651858.CD011561.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011561.pub2&amp;doi=10.1002/14651858.CD011561.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011561.pub2&amp;doi=10.1002/14651858.CD011561.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011561.pub2&amp;doi=10.1002/14651858.CD011561.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011561.pub2&amp;doi=10.1002/14651858.CD011561.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011561.pub2&amp;doi=10.1002/14651858.CD011561.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="KUoIaN9D";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD011561\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD011561\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011561\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011561\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","fa","fr","ms"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD011561.pub2",title:"Band ligation versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis",firstPublishedDate:"Jan 26, 2021 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Hepato-Biliary Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=KUoIaN9D&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011561.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011561.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD011561.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD011561.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011561.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD011561.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011561.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD011561.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011561.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD011561.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD011561.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD011561.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD011561.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD011561.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>1252 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD011561.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011561.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011561.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011561.pub2/full#CD011561-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011561.pub2/full#CD011561-sec-0082"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011561.pub2/full#CD011561-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011561.pub2/full#CD011561-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011561.pub2/full#CD011561-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011561.pub2/full#CD011561-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011561.pub2/full#CD011561-sec-0053"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011561.pub2/full#CD011561-sec-0076"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD011561.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011561.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011561.pub2/appendices#CD011561-sec-0087"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011561.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011561.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD011561.pub2/media/CDSR/CD011561/table_n/CD011561StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD011561.pub2/media/CDSR/CD011561/table_n/CD011561StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011561.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011561.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011561.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011561.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011561.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD011561.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2021 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD011561.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Band ligation versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011561.pub2/information#CD011561-cr-0004">Lorena I Cifuentes</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011561.pub2/information#CD011561-cr-0005">Daniela Gattini</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011561.pub2/information#CD011561-cr-0006">Romina Torres-Robles</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011561.pub2/information#CD011561-cr-0007"><i class="icon corresponding-author fa fa-envelope"></i>Juan Cristóbal Gana</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD011561.pub2/information/en#CD011561-sec-0091">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 26 January 2021 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD011561.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD011561.pub2">https://doi.org/10.1002/14651858.CD011561.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD011561-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011561-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011561-abs-0010">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011561-abs-0005">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD011561-abs-0007">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011561-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD011561-abs-0001" lang="en"> <section id="CD011561-sec-0001"> <h3 class="title" id="CD011561-sec-0001">Background</h3> <p>Portal hypertension commonly accompanies advanced liver disease and often gives rise to life‐threatening complications, including bleeding (haemorrhage) from oesophageal and gastrointestinal varices. Variceal bleeding commonly occurs in children and adolescents with chronic liver disease or portal vein thrombosis. Prevention is, therefore, important. Randomised clinical trials have shown that non‐selective beta‐blockers and endoscopic variceal band ligation decrease the incidence of variceal bleeding in adults. In children and adolescents, band ligation, beta‐blockers, and sclerotherapy have been proposed as primary prophylaxis alternatives for oesophageal variceal bleeding. However, it is unknown whether these interventions are of benefit or harm when used for primary prophylaxis in children and adolescents. </p> </section> <section id="CD011561-sec-0002"> <h3 class="title" id="CD011561-sec-0002">Objectives</h3> <p>To assess the benefits and harms of band ligation compared with sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis. </p> </section> <section id="CD011561-sec-0003"> <h3 class="title" id="CD011561-sec-0003">Search methods</h3> <p>We searched the Cochrane Hepato‐Biliary Group Controlled Trials Register, CENTRAL, PubMed, Embase, and two other databases (April 2020). We scrutinised the reference lists of the retrieved publications, and we also handsearched abstract books of the two main paediatric gastroenterology and hepatology conferences from January 2008 to December 2019. We also searched clinicaltrials.gov, the United States Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the World Health Organization (WHO) for ongoing clinical trials. We imposed no language or document type restrictions on our search. </p> </section> <section id="CD011561-sec-0004"> <h3 class="title" id="CD011561-sec-0004">Selection criteria</h3> <p>We aimed to include randomised clinical trials irrespective of blinding, language, or publication status, to assess the benefits and harms of band ligation versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis. If the search for randomised clinical trials retrieved quasi‐randomised and other observational studies, then we read them through to extract information on harm. </p> </section> <section id="CD011561-sec-0005"> <h3 class="title" id="CD011561-sec-0005">Data collection and analysis</h3> <p>We used standard Cochrane methodology to perform this systematic review. We used GRADE to assess the certainty of evidence for each outcome. Our primary outcomes were all‐cause mortality, serious adverse events and liver‐related morbidity, and quality of life. Our secondary outcomes were oesophageal variceal bleeding and adverse events not considered serious. We used the intention‐to‐treat principle. We analysed data using Review Manager 5. </p> </section> <section id="CD011561-sec-0006"> <h3 class="title" id="CD011561-sec-0006">Main results</h3> <p>One conference abstract, describing a feasibility multi‐centre randomised clinical trial, fulfilled our review inclusion criteria. We judged the trial at overall high risk of bias. This trial was conducted in three hospital centres in the United Kingdom. The aim of the trial was to determine the feasibility and safety of further larger randomised clinical trials of prophylactic band ligation versus no active treatment in children with portal hypertension and large oesophageal varices. Twelve children received prophylactic band ligation and 10 children received no active treatment. There was no information on the age of the children included, or about the diagnosis of any child included. All children were followed up for at least six months. Mortality was 8% (1/12) in the band ligation group versus 0% (0/10) in the no active intervention group (risk ratio (RR) 2.54, 95% confidence interval (CI) 0.11 to 56.25; very low certainty of evidence). The abstract did not report when the death occurred, but we assume it happened between the six‐month follow‐up and one year. No child (0%) in the band ligation group developed adverse events (RR 0.28, 95% CI 0.01 to 6.25; very low certainty of evidence) but one child out of 10 (10%) in the no active intervention group developed idiopathic thrombocytopaenic purpura. One child out of 12 (8%) in the band ligation group underwent liver transplantation versus none in the no active intervention group (0%) (RR 2.54, 95% CI 0.11 to 56.25; very low certainty of evidence). The trial reported no other serious adverse events or liver‐related morbidity. Quality of life was not reported. Oesophageal variceal bleeding occurred in 8% (1/12) of the children in the band ligation group versus 30% (3/10) of the children in the no active intervention group (RR 0.28, 95% CI 0.03 to 2.27; very low certainty of evidence). No adverse events considered non‐serious were reported. Two children were lost to follow‐up by one‐year. Ten children in total completed the trial at two‐year follow‐up. There was no information on funding.  </p> <p>We found two observational studies on endoscopic variceal ligation when searching for randomised trials. One found no harm, and the other reported <i>E</i> <i>nterobacter</i> <i>cloacae</i> septicaemia in one child and mild, transient, upper oesophageal sphincter stenosis in another. We did not assess these studies for risk of bias. </p> <p>We did not find any ongoing randomised clinical trials of interest to our review.</p> </section> <section id="CD011561-sec-0007"> <h3 class="title" id="CD011561-sec-0007">Authors' conclusions</h3> <p>The evidence, obtained from only one feasibility randomised clinical trial at high risk of bias, is very scanty. It is very uncertain about whether prophylactic band ligation versus sham or no (active) intervention may affect mortality, serious adverse events and liver‐related morbidity, or oesophageal variceal bleeding in children and adolescents with portal hypertension and large oesophageal varices. We have no data on quality of life. No adverse events considered non‐serious were reported. The results presented in the trial need to be interpreted with caution. In addition, the highly limited data cover only part of our research question; namely, children with portal hypertension and large oesophageal varices. Data on children with portal vein thrombosis are lacking. </p> <p>Larger randomised clinical trials assessing the benefits and harms of band ligation compared with sham treatment for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis are needed. The trials should include important clinical outcomes such as death, quality of life, failure to control bleeding, and adverse events. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD011561-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011561-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011561-abs-0011">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011561-abs-0006">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD011561-abs-0008">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD011561-abs-0009">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011561-abs-0004">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD011561-abs-0002" lang="en"> <h3>In children with liver disease, who have enlarged veins in the oesophagus (food pipe), does placing an elastic ring around the vein prevent it from bleeding? </h3> <p><b>Bleeding in the oesophagus</b><br/>A blood clot in the veins that drain blood from the digestive tract into the liver (known as portal vein thrombosis) causes increased pressure in these veins. Increased blood pressure in the veins supplying blood to the liver is also common in serious liver disease. The increased pressure can make the veins in the oesophagus (the tube running from the throat to the stomach) swollen and enlarged. Bleeding from enlarged veins in the oesophagus is a life‐threatening condition. </p> <p><b>How are enlarged veins in the oesophagus treated?</b><br/>In adults, studies have shown two treatments work well to treat bleeding from enlarged veins: </p> <p>‐ taking medicines called beta‐blockers; and<br/>‐ placing an elastic ring around the vein to cut off the blood flow through it. </p> <p>These two treatments have become the main ways to prevent bleeding from enlarged veins in the oesophagus in adults. However, we do not know how well these treatments work in children and young people, or if they cause any unwanted effects or harms.   </p> <p><b>Why we did this Cochrane Review</b><br/>We wanted to assess the benefits and harms of placing an elastic ring around an enlarged vein to prevent it from bleeding, in children with long‐lasting liver disease or portal vein thrombosis. </p> <p><b>What we did</b><br/>We searched for studies that tested the effects of placing an elastic ring around an enlarged vein in the oesophagus to prevent it from bleeding, compared with a sham treatment (the same procedure, but no band was placed) or no treatment, in children with long‐lasting liver disease or portal vein thrombosis. </p> <p>We looked for randomised clinical studies, in which the people taking part are randomly placed into different intervention groups. This type of study, if performed correctly, usually gives the most reliable evidence about the effects of a treatment. </p> <p>We wanted to find out about:</p> <p>‐ how many children died;</p> <p>‐ how many children had serious unwanted effects (effects considered life‐threatening or that needed hospital treatment) or liver‐related diseases; </p> <p>‐ the children's well‐being (quality of life);</p> <p>‐ how many children had oesophageal bleeding; and</p> <p>‐ how many children had any unwanted effects that were not considered serious.</p> <p><b>How current is the evidence?</b><br/>The evidence in this review includes research published up to 27 April 2020. </p> <p><b>What we found</b><br/>We found only one report of a study that took place at three hospitals in the UK. It was a feasibility study: it looked at whether it would be possible to conduct larger and more conclusive randomised studies. A summary of the study data was published and presented at a conference. The study report was not good enough to judge the quality of the study. No information about funding was given. </p> <p>We did not find any other studies that could be included in this review, and there are no ongoing randomised studies. </p> <p><b>What are the main results?</b><br/>The study randomised 22 children with portal hypertension and enlarged veins into two groups: </p> <p>‐ one group had an elastic ring placed around the enlarged vein (12 children); and<br/>‐ one group had no active treatment (10 children). </p> <p>There was no information about the diagnosis, or age, of any of the children. The children were followed for at least six months. Two children were lost to follow‐up by one year. Only 10 children in total completed the trial study at two‐year follow‐up. </p> <p>In the group who had an elastic ring placed:</p> <p>‐ one child died;<br/>‐ no children had any other serious unwanted effects;<br/>‐ one child needed a liver transplant; and <br/>‐ one child had oesophageal bleeding. </p> <p>In the group who received no active treatment:</p> <p>‐ no children died; <br/>‐ one child had a serious unwanted effect: an immune disorder in which blood does not clot properly (idiopathic thrombocytopaenic purpura); <br/>‐ no children needed a liver transplant; and<br/>‐ three children had oesophageal bleeding. </p> <p>No unwanted effects that were less serious were reported in either group. The study did not report any information about the children's well‐being (quality of life). </p> <p><b>Conclusions</b><br/>The insufficient and poor reporting of results from one small, randomised study, and the lack of other randomised studies, mean that we cannot draw trustworthy conclusions. We do not know how well elastic rings work to prevent bleeding from enlarged veins in the oesophagus in children and young people, or about any unwanted effects they might cause. </p> <p>Until good‐quality randomised studies take place and measure the numbers of deaths, quality of life, failure to control bleeding, and unwanted effects, we will not know if elastic rings are a good treatment to prevent bleeding in children and young people with long‐lasting liver disease or portal vein thrombosis. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD011561-sec-0082" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD011561-sec-0082"></div> <h3 class="title" id="CD011561-sec-0083">Implications for practice</h3> <section id="CD011561-sec-0083"> <p>The evidence, obtained from only one feasibility randomised clinical trial at high risk of bias and at high risk of imprecision, is very uncertain on whether prophylactic band ligation may affect mortality, liver transplantation or other liver‐related morbidity, or oesophageal variceal bleeding in children with portal hypertension and large oesophageal varices. Idiopathic thrombocytopaenic purpura was observed in one child in the no active intervention group. Apart from liver transplantation, no other serious adverse events were reported in the band ligation group. Quality of life was not reported. Non‐serious adverse events were not reported. The GRADE assessment of each outcome showed a very low‐certainty of evidence. The results of the trial need to be interpreted with caution. In addition, the scanty data cover only part of our research question ‐ namely, children with portal hypertension and large oesophageal varices. </p> <p>Larger randomised clinical trials assessing the benefits and harms of band ligation compared with sham for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis are needed. </p> </section> <h3 class="title" id="CD011561-sec-0084">Implications for research</h3> <section id="CD011561-sec-0084"> <p>This systematic review has identified the need for well‐designed, adequately powered, multi‐centre randomised clinical trials to assess the benefits and harms of band ligation versus sham for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis. The randomised clinical trials should include patient‐relevant clinical outcomes such as mortality, quality of life, failure to control bleeding, and adverse events. The trials should be designed according to the SPIRIT statements (<a href="./references#CD011561-bbs2-0011" title="ChanAW , TetzlaffJM , GotzschePC , AltmanDG , MannH , BerlinJA , et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ (Clinical research ed.)2013;346:e7586. [PMID: 23303884]">Chan 2013</a>), the Foundation of Patient‐Centered Outcomes Research recommendations (<a href="./references#CD011561-bbs2-0052" title="BaschE , AronsonN , BergA , FlumD , GabrielS , GoodmanSN , et al. Methodological standards and patient-centeredness in comparative effectiveness research: the PCORI perspective. JAMA2012;307(15):1636-40. [PMID: 22511692]">PCORI 2012</a>), and be reported according to the CONSORT statements (<a href="http://www.consort-statement.org/" target="_blank">www.consort-statement.org/</a>). </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD011561-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD011561-sec-0008"></div> <div class="table" id="CD011561-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Band ligation compared to sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Band ligation versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> children with portal hypertension and large oesophageal varices, without previous gastrointestinal bleeding or beta‐blocker treatment<br/><b>Setting:</b> pilot study in three hospital centres in United Kingdom<br/><b>Intervention:</b> band ligation<br/><b>Comparison: </b>no active treatment </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(trials)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with sham or no intervention</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with band ligation</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All‐cause mortality<br/>Follow‐up: </p> <p>at minimum 6 months*</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1,000<br/>(0 to 0 ) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 2.54<br/>(0.11 to 56.25) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊝⊝⊝⊝<br/>Very low <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All‐cause mortality was 8% (1/12) in the band ligation group and 0% (0/10) in the no active intervention group </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Serious adverse events</p> <p>Idiopathic thrombocytopaenic purpura</p> <p>Follow‐up: at minimum 6 months*</p> <p>and</p> <p>Liver‐related morbidity:</p> <p>‐ liver transplantation<br/>Follow‐up: at minimum 6 months* </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>100 per 1,000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>28 per 1,000<br/>(1 to 625) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.28 (0.01 to 6.25)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝</p> <p>Very low <sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 out of 12 children (0%) in the band ligation group developed idiopathic thrombocytopaenic purpura versus 1 out of 10 (10%) in the no active intervention group. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1,000<br/>( 0 to 0) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 2.54<br/>(0.11 to 56.25) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝</p> <p>Very low <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/12 children (8%) randomised to band ligation underwent liver transplantation while 0/10 children (0%) in the no active intervention group underwent liver transplantation </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Health‐related quality of life</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Outcome not assessed in the trial</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oesophageal variceal bleeding<br/>Follow‐up: at minimum 6 months* </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>300 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>84 per 1,000<br/>(9 to 681) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.28<br/>(0.03 to 2.27) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low <sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oesophageal variceal bleeding occurred in 8% (1/12) of the children in the band ligation group and in 30% (3/10) of the children in the no active intervention group. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse events considered</p> <p>not serious</p> <p>Follow‐up: at minimum 6 months*</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not assessable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; <b>RCT</b> : randomised clinical trial; <b>OIS</b>: optimal information size </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>* Although the trial abstract reported the maximum follow‐up to be two years, it did not specify the time when events occurred for all participants. The trial reported: "All have completed at least six months follow‐up; after the first year the treatment protocol was relaxed to allow fewer variceal band ligation sessions; and 10 have completed the study." 10 children in total seemed to have completed the trial at two‐year follow‐up. </p> <p><sup>1</sup> Downgraded because of: risk of bias (two levels): blinding of participants and personnel (performance bias) was at high risk of bias, and all other domains were at unclear risk of bias; imprecision (two levels): few events; and the CI of the point estimate is very wide and includes both benefit and harm. </p> <p><sup>2</sup>Downgraded because of: risk of bias (two levels): blinding of participants and personnel (performance bias) was at high risk of bias, and all other domains were at unclear risk of bias; imprecision (two levels): the OIS of 2005 participants was not met; few events; and the CI of the point estimate is very wide and includes both benefit and harm. </p> <p><sup>3</sup>Downgraded because of: risk of bias (two levels): blinding of participants and personnel (performance bias) was at high risk of bias, and all other domains were at unclear risk of bias; imprecision (two levels): the OIS of 540 participants was not met; few events; and the CI of the point estimate includes both benefit and harm. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD011561-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD011561-sec-0009"></div> <section id="CD011561-sec-0010"> <h3 class="title" id="CD011561-sec-0010">Description of the condition</h3> <p>There are scarce data on the prevalence and burden of liver disease in children and adolescents. However, we know that the natural history of portal hypertension in children and adolescents is different from that in adults. In adults, the cause of portal hypertension is mostly intrahepatic, whereas the cause in children is mostly extrahepatic. The main underlying condition which results in the development of portal hypertension in children is extrahepatic portal vein thrombosis (<a href="./references#CD011561-bbs2-0015" title="Di GiorgioA , De AngelisP , CheliM , VajroP , IorioR , CananziM , et al. Etiology, presenting features and outcome of children with non-cirrhotic portal vein thrombosis: a multicentre national study. Digestive and Liver Disease2019;51(8):1179-84. [PMID: 30928422]">Di Giorgio 2019</a>), followed by cirrhotic aetiologies, such as biliary atresia (<a href="./references#CD011561-bbs2-0066" title="ShneiderBL , deVille de GoyetJ , LeungDH , SrivastavaA , LingSC , DucheM , et al. Primary prophylaxis of variceal bleeding in children and the role of MesoRex Bypass: summary of the Baveno VI Pediatric Satellite Symposium. Hepatology (Baltimore, Md.)2016;63(4):1368-80. [PMID: 26358549]">Shneider 2016</a>; <a href="./references#CD011561-bbs2-0012" title="ChapinCA , BassLM . Cirrhosis and portal hypertension in the pediatric population. Clinics in Liver Disease2018;22(4):735-52. [PMID: 30266160]">Chapin 2018</a>). In adults with portal hypertension, hepatic venous pressure gradient (HVPG) of 10 mmHg or more has been associated with the formation of oesophageal varices, variceal bleeding or ascites, or both (<a href="./references#CD011561-bbs2-0019" title="EbelNH , CarlinK , ShafferML , ShivaramG , HawkinsM , LaneER , et al. Hepatic venous pressure gradient measurements in children: correlation with hepatic histology and clinical indicators of portal hypertension. Journal of Pediatric Gastroenterology and Nutrition2019;68(6):788-92. [PMID: 30921261]">Ebel 2019</a>). The risk of oesophageal variceal bleeding is increased at HVPG of 12 mmHg or more (<a href="./references#CD011561-bbs2-0014" title="de Franchis R, Baveno VI Faculty. Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. Journal of Hepatology2015;63:743–52.">de Franchis 2015</a>). However, there are limited data on HVPG gradient in children. A recent study in children with portal hypertension found that HVPG was not associated with the presence of varices or history of variceal bleeding, suggesting the possibility of intrahepatic shunting in children with advanced liver disease (<a href="./references#CD011561-bbs2-0019" title="EbelNH , CarlinK , ShafferML , ShivaramG , HawkinsM , LaneER , et al. Hepatic venous pressure gradient measurements in children: correlation with hepatic histology and clinical indicators of portal hypertension. Journal of Pediatric Gastroenterology and Nutrition2019;68(6):788-92. [PMID: 30921261]">Ebel 2019</a>). The study by <a href="./references#CD011561-bbs2-0019" title="EbelNH , CarlinK , ShafferML , ShivaramG , HawkinsM , LaneER , et al. Hepatic venous pressure gradient measurements in children: correlation with hepatic histology and clinical indicators of portal hypertension. Journal of Pediatric Gastroenterology and Nutrition2019;68(6):788-92. [PMID: 30921261]">Ebel 2019</a> also suggested that "the use of HVPG measurements alone may not capture all children at risk for adverse clinical outcomes secondary to portal hypertension". </p> <p>Variceal haemorrhage (bleeding) is common in children with portal hypertension due to a chronic liver disease or portal vein thrombosis (<a href="./references#CD011561-bbs2-0047" title="LykavierisP , GauthierF , HadchouelP , DucheM , BernardO . Risk of gastrointestinal bleeding during adolescence and early adulthood in children with portal vein obstruction. Journal of Pediatrics2000;136(6):805-8. [PMID: 10839880]">Lykavieris 2000</a>; <a href="./references#CD011561-bbs2-0049" title="MigaD , SokolRJ , MackenzieT , NarkewiczMR , SmithD , KarrerFM . Survival after first esophageal variceal hemorrhage in patients with biliary atresia. Journal of Pediatrics2001;139(2):291-6. [PMID: 11487759]">Miga 2001</a>; <a href="./references#CD011561-bbs2-0071" title="Van HeurnLW , SaingH , TamPK . Portoenterostomy for biliary atresia: long-term survival and prognosis after esophageal variceal bleeding. Journal of Pediatric Surgery2004;39(1):6-9. [PMID: 14694362]">Van Heurn 2004</a>; <a href="./references#CD011561-bbs2-0015" title="Di GiorgioA , De AngelisP , CheliM , VajroP , IorioR , CananziM , et al. Etiology, presenting features and outcome of children with non-cirrhotic portal vein thrombosis: a multicentre national study. Digestive and Liver Disease2019;51(8):1179-84. [PMID: 30928422]">Di Giorgio 2019</a>). A study of 125 children with biliary atresia, with signs of portal hypertension or previous history of gastrointestinal bleeding, reported that 88 children (70%) developed oesophageal varices (<a href="./references#CD011561-bbs2-0016" title="DucheM , DucotB , TournayE , FabreM , CohenJ , JacqueminE , et al. Prognostic value of endoscopy in children with biliary atresia at risk for early development of varices and bleeding. Gastroenterology2010;139(6):1952-60. [PMID: 20637201]">Duche 2010</a>). Several other studies reported incidence of variceal haemorrhage in children with biliary atresia within the range of 15% to 29% (<a href="./references#CD011561-bbs2-0049" title="MigaD , SokolRJ , MackenzieT , NarkewiczMR , SmithD , KarrerFM . Survival after first esophageal variceal hemorrhage in patients with biliary atresia. Journal of Pediatrics2001;139(2):291-6. [PMID: 11487759]">Miga 2001</a>; <a href="./references#CD011561-bbs2-0071" title="Van HeurnLW , SaingH , TamPK . Portoenterostomy for biliary atresia: long-term survival and prognosis after esophageal variceal bleeding. Journal of Pediatric Surgery2004;39(1):6-9. [PMID: 14694362]">Van Heurn 2004</a>; <a href="./references#CD011561-bbs2-0065" title="ShneiderBL , AbelB , HaberB , KarpenSJ , MageeJC , RomeroR , et al. Portal hypertension in children and young adults with biliary atresia. Journal of Pediatric Gastroenterology and Nutrition2012;55(5):567-73. [PMID: 22903006]">Shneider 2012b</a>; <a href="./references#CD011561-bbs2-0044" title="LeeWS , OngSY , FooHW , WongSY , KongCX , SeahRB , et al. Chronic liver disease is universal in children with biliary atresia living with native liver. World Journal of Gastroenterology2017;23(43):7776-84. [PMID: 29209118]">Lee 2017</a>; <a href="./references#CD011561-bbs2-0072" title="Van WesselDB , WittM , BaxN , VerkadeHJ , ScheenstraR , De KleineRH , et al. Variceal bleeds in patients with biliary atresia. European Journal of Pediatric Surgery2018;28(5):439-44. [PMID: 28658682]">Van Wessel 2018</a>). <a href="./references#CD011561-bbs2-0032" title="GoncalvesME , CardosoSR , MaksoudJG . Prophylactic sclerotherapy in children with esophageal varices: long-term results of a controlled prospective randomized trial. Journal of Pediatric Surgery2000;35(3):401-5. [PMID: 10726678]">Goncalves 2000</a> prospectively followed 50 children with oesophageal varices that were primarily due to cirrhosis. None of the children received active treatment to prevent variceal bleeding. In this study, 42% suffered upper gastrointestinal haemorrhage within a median follow‐up period of 4.5 year (<a href="./references#CD011561-bbs2-0032" title="GoncalvesME , CardosoSR , MaksoudJG . Prophylactic sclerotherapy in children with esophageal varices: long-term results of a controlled prospective randomized trial. Journal of Pediatric Surgery2000;35(3):401-5. [PMID: 10726678]">Goncalves 2000</a>). For children with portal vein thrombosis, studies suggest that up to 50% of the children suffer a major variceal haemorrhage by the age of 16 (<a href="./references#CD011561-bbs2-0047" title="LykavierisP , GauthierF , HadchouelP , DucheM , BernardO . Risk of gastrointestinal bleeding during adolescence and early adulthood in children with portal vein obstruction. Journal of Pediatrics2000;136(6):805-8. [PMID: 10839880]">Lykavieris 2000</a>). A more recent study by <a href="./references#CD011561-bbs2-0015" title="Di GiorgioA , De AngelisP , CheliM , VajroP , IorioR , CananziM , et al. Etiology, presenting features and outcome of children with non-cirrhotic portal vein thrombosis: a multicentre national study. Digestive and Liver Disease2019;51(8):1179-84. [PMID: 30928422]">Di Giorgio 2019</a>, including 187 patients with portal hypertension due to non‐cirrhotic portal vein thrombosis, found that 67 (36%) patients were diagnosed following gastrointestinal bleeding. Of the 71 patients who had endoscopy at presentation, 62 (87%) had oesophageal varices (<a href="./references#CD011561-bbs2-0015" title="Di GiorgioA , De AngelisP , CheliM , VajroP , IorioR , CananziM , et al. Etiology, presenting features and outcome of children with non-cirrhotic portal vein thrombosis: a multicentre national study. Digestive and Liver Disease2019;51(8):1179-84. [PMID: 30928422]">Di Giorgio 2019</a>). </p> <p>A mortality rate of 19% was reported within 35 days of variceal bleeding episodes among North American children with liver disease of various aetiologies (<a href="./references#CD011561-bbs2-0020" title="ErogluY , EmerickKM , WhitingonPF , AlonsoEM . Octreotide therapy for control of acute gastrointestinal bleeding in children. Journal of Pediatric Gastroenterology and Nutrition2004;38(1):41-7. [PMID: 14676593]">Eroglu 2004</a>). Two other studies showed that 5% and 15% of children with biliary atresia and variceal bleeding were expected to die (<a href="./references#CD011561-bbs2-0068" title="StringerMD , HowardER , MowatAP . Endoscopic sclerotherapy in the management of esophageal varices in 61 children with biliary atresia. Journal of Pediatric Surgery1989;24(5):438-42. [PMID: 2786958]">Stringer 1989</a>; <a href="./references#CD011561-bbs2-0071" title="Van HeurnLW , SaingH , TamPK . Portoenterostomy for biliary atresia: long-term survival and prognosis after esophageal variceal bleeding. Journal of Pediatric Surgery2004;39(1):6-9. [PMID: 14694362]">Van Heurn 2004</a>, respectively). In contrast, variceal bleeding in children with portal vein thrombosis and no parenchymal liver disease seemed to carry a lower risk of death (i.e. less than 3%) (<a href="./references#CD011561-bbs2-0047" title="LykavierisP , GauthierF , HadchouelP , DucheM , BernardO . Risk of gastrointestinal bleeding during adolescence and early adulthood in children with portal vein obstruction. Journal of Pediatrics2000;136(6):805-8. [PMID: 10839880]">Lykavieris 2000</a>). </p> <p>Specific endoscopic variceal patterns have been shown to be predictive of the risk of gastrointestinal bleeding. Grade 1 varices are small varices that extend just above the mucosal level. Grade 2 varices project in less than one‐third of the luminal diameter and cannot be compressed with air insufflation. Grade 3 varices are large varices that occupy more than one‐third of the luminal diameter. In children with biliary atresia, grade 3 varices and grade 2 varices with oesophageal red markings and the presence of gastric varices, have been reported to be independent risk factors for bleeding (<a href="./references#CD011561-bbs2-0017" title="DucheM , DucotB , AckermannO , BaujardC , ChevretL , Frank-SoltysiakM , et al. Experience with endoscopic management of high-risk gastroesophageal varices, with and without bleeding, in children with biliary atresia. Gastroenterology2013;145(4):801-7. [PMID: 23792202]">Duche 2013</a>; <a href="./references#CD011561-bbs2-0018" title="DucheM , DucotB , AckermannO , GuerinF , JacqueminE , BernardO . Portal hypertension in children: high-risk varices, primary prophylaxis and consequences of bleeding. Journal of Hepatology2017;66(2):320-7. [PMID: 27663417]">Duche 2017</a>). However, the data regarding endoscopic pattern of gastroesophageal varices predicting high risk of bleeding in children with portal vein thrombosis and other causes of portal hypertension are limited (<a href="./references#CD011561-bbs2-0066" title="ShneiderBL , deVille de GoyetJ , LeungDH , SrivastavaA , LingSC , DucheM , et al. Primary prophylaxis of variceal bleeding in children and the role of MesoRex Bypass: summary of the Baveno VI Pediatric Satellite Symposium. Hepatology (Baltimore, Md.)2016;63(4):1368-80. [PMID: 26358549]">Shneider 2016</a>; <a href="./references#CD011561-bbs2-0012" title="ChapinCA , BassLM . Cirrhosis and portal hypertension in the pediatric population. Clinics in Liver Disease2018;22(4):735-52. [PMID: 30266160]">Chapin 2018</a>; <a href="./references#CD011561-bbs2-0055" title="QuinteroJ , JuampérezJ , Mercadal-HallyM , JulioE , OrtegaJ , MolinoJA , et al. Endoscopic variceal ligation as primary prophylaxis for upper gastrointestinal bleeding in children. Journal of Pediatric Gastroenterology and Nutrition2019;68(Suppl 1):706.">Quintero 2019</a>; <a href="./references#CD011561-bbs2-0056" title="QuinteroJ , JuampérezJ , Mercadal-HallyM , KingML , OrtegaJ , MolinoJA , et al. Endoscopic variceal ligation as primary prophylaxis for upper GI bleeding in children. Gastrointestinal Endoscopy2020;92(2):269-75. [DOI: 10.1016/j.gie.2020.02.035]">Quintero 2020</a>). </p> </section> <section id="CD011561-sec-0011"> <h3 class="title" id="CD011561-sec-0011">Description of the intervention</h3> <p>Band ligation is an endoscopic procedure in which an enlarged vein in the oesophagus is ligated by a rubber band. Numerous randomised clinical trials have shown the benefits of non‐selective beta‐blockers and endoscopic variceal band ligation as treatment modalities against acute variceal haemorrhage in adults. These interventions are also the established standard of primary prevention in adults (<a href="./references#CD011561-bbs2-0026" title="Garcia-TsaoG , SanyalAJ , GraceND , CareyWD . Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. American Journal of Gastroenterology2007;102(9):2086-102. [PMID: 17727436]">Garcia‐Tsao 2007</a>; <a href="./references#CD011561-bbs2-0027" title="Garcia-TsaoG , BoschJ , GroszmannRJ . Portal hypertension and variceal bleeding - unresolved issues. Summary of an American Association for the Study of Liver Diseases and European Association for the Study of the Liver single-topic conference. Hepatology (Baltimore, Md.)2008;47(5):1764-72. [PMID: 18435460]">Garcia‐Tsao 2008</a>; <a href="./references#CD011561-bbs2-0031" title="GluudLL , KragA . Banding ligation versus beta-blockers for primary prevention in oesophageal varices in adults. Cochrane Database of Systematic Reviews2012, Issue 8. Art. No: CD004544. [DOI: 10.1002/14651858.CD004544.pub2]">Gluud 2012</a>; <a href="./references#CD011561-bbs2-0028" title="Garcia-TsaoG , AbraldesJG , BerzigottiA , BoschJ . Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology (Baltimore, Md.)2017;65(1):310-35. [PMID: 27786365]">Garcia‐Tsao 2017</a>). No evidence‐based recommendations for the prophylactic management of variceal haemorrhage in children and adolescents at risk exist because of the lack of appropriate, good quality, randomised clinical trials (<a href="./references#CD011561-bbs2-0066" title="ShneiderBL , deVille de GoyetJ , LeungDH , SrivastavaA , LingSC , DucheM , et al. Primary prophylaxis of variceal bleeding in children and the role of MesoRex Bypass: summary of the Baveno VI Pediatric Satellite Symposium. Hepatology (Baltimore, Md.)2016;63(4):1368-80. [PMID: 26358549]">Shneider 2016</a>). </p> <p>There are several differences in the pathophysiology of portal hypertension in adults versus in children and adolescents, so extrapolation of results from the former to the latter must be done cautiously. The principal aetiologies of liver disease and portal hypertension are different in these populations. In children, the main causes of portal hypertension are biliary atresia and portal vein thrombosis, while in adults they are hepatitis C and alcohol‐related cirrhosis. Although band ligation is frequently used in children, there is a limitation, as the band ligation device currently available is too large to be introduced into the oesophagi of children weighing less than 10 kg. </p> </section> <section id="CD011561-sec-0012"> <h3 class="title" id="CD011561-sec-0012">How the intervention might work</h3> <p>Endoscopic variceal ligation and beta‐blockers have been shown to be the best treatment modalities in adults (<a href="./references#CD011561-bbs2-0026" title="Garcia-TsaoG , SanyalAJ , GraceND , CareyWD . Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. American Journal of Gastroenterology2007;102(9):2086-102. [PMID: 17727436]">Garcia‐Tsao 2007</a>; <a href="./references#CD011561-bbs2-0027" title="Garcia-TsaoG , BoschJ , GroszmannRJ . Portal hypertension and variceal bleeding - unresolved issues. Summary of an American Association for the Study of Liver Diseases and European Association for the Study of the Liver single-topic conference. Hepatology (Baltimore, Md.)2008;47(5):1764-72. [PMID: 18435460]">Garcia‐Tsao 2008</a>; <a href="./references#CD011561-bbs2-0031" title="GluudLL , KragA . Banding ligation versus beta-blockers for primary prevention in oesophageal varices in adults. Cochrane Database of Systematic Reviews2012, Issue 8. Art. No: CD004544. [DOI: 10.1002/14651858.CD004544.pub2]">Gluud 2012</a>; <a href="./references#CD011561-bbs2-0028" title="Garcia-TsaoG , AbraldesJG , BerzigottiA , BoschJ . Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology (Baltimore, Md.)2017;65(1):310-35. [PMID: 27786365]">Garcia‐Tsao 2017</a>). Band ligation leads to mechanical obliteration of the varices, reducing the intra‐varix blood flow. A 2001 meta‐analysis showed that endoscopic variceal ligation for primary prophylaxis of oesophageal varices in adults with cirrhosis reduced the incidence of variceal haemorrhage and mortality by 64% compared with no therapy (<a href="./references#CD011561-bbs2-0039" title="ImperialeTF , ChalasaniN . A meta-analysis of endoscopic variceal ligation for primary prophylaxis of esophageal variceal bleeding. Hepatology (Baltimore, Md.)2001;33(4):802-7. [PMID: 11283842]">Imperiale 2001</a>). Moreover, band ligation seems to be superior compared with beta‐blockers in reducing variceal bleeding (<a href="./references#CD011561-bbs2-0031" title="GluudLL , KragA . Banding ligation versus beta-blockers for primary prevention in oesophageal varices in adults. Cochrane Database of Systematic Reviews2012, Issue 8. Art. No: CD004544. [DOI: 10.1002/14651858.CD004544.pub2]">Gluud 2012</a>). Considering this information, it seems reasonable to consider this intervention as a prophylactic option in children and adolescents with oesophageal varices (<a href="./references#CD011561-bbs2-0010" title="BozicMA , PuriK , MollestonJP . Screening and prophylaxis for varices in children with liver disease. Current Gastroenterology Reports2015;17(7):27. [PMID: 26122248]">Bozic 2015</a>; <a href="./references#CD011561-bbs2-0053" title="PimentaJR , FerreiraAR , BittencourtPF , ResendeCB , FagundesED , SilvaIM . Evaluation of primary prophylaxis with propranolol and elastic band ligation in variceal bleeding in cirrhotic children and adolescents. Archives of Gastroenterology2016;53(4):257-61. [PMID: 27706456]">Pimenta 2016</a>). </p> </section> <section id="CD011561-sec-0013"> <h3 class="title" id="CD011561-sec-0013">Why it is important to do this review</h3> <p>Variceal haemorrhage commonly occurs in children and adolescents with oesophageal varices secondary to chronic liver disease or portal vein thrombosis, and, as it has been associated with mortality (<a href="./references#CD011561-bbs2-0050" title="MiletiE , RosenthalP . Management of portal hypertension in children. Current Gastroenterology Reports2011;13(1):10-6. [PMID: 20927620]">Mileti 2011</a>; <a href="./references#CD011561-bbs2-0012" title="ChapinCA , BassLM . Cirrhosis and portal hypertension in the pediatric population. Clinics in Liver Disease2018;22(4):735-52. [PMID: 30266160]">Chapin 2018</a>), prevention is important. Identification of how to prevent it is one of the most important areas that needs to be addressed in children with portal hypertension (<a href="./references#CD011561-bbs2-0021" title="GanaJC , TurnerD , RobertsEA , LingSC . Derivation of a clinical prediction rule for the noninvasive diagnosis of varices in children. Journal of Pediatric Gastroenterology and Nutrition2010;50(2):188-93. [PMID: 19966576]">Gana 2010</a>; <a href="./references#CD011561-bbs2-0023" title="GanaJC , TurnerD , Mieli-VerganiG , DavenportM , MilohT , AvitzurY , et al. A clinical prediction rule and platelet count predict esophageal varices in children. Gastroenterology2011;141(6):2009-16. [PMID: 21925123]">Gana 2011b</a>; <a href="./references#CD011561-bbs2-0045" title="LingSC , WaltersT , McKiernanPJ , SchwarzKB , Garcia-TsaoG , ShneiderBL . Primary prophylaxis of variceal hemorrhage in children with portal hypertension: a framework for future research. Journal of Pediatric Gastroenterology and Nutrition2011;52(3):254-61. [PMID: 21336158]">Ling 2011</a>; <a href="./references#CD011561-bbs2-0064" title="ShneiderBL , BoschJ , deFranchisR , EmreSH , GroszmannRJ , LingSC , et al. Portal hypertension in children: expert pediatric opinion on the report of the Baveno V Consensus Workshop on Methodology of Diagnosis and Therapy in Portal Hypertension. Pediatric Transplantation2012;16(5):426-37. [PMID: 22409296]">Shneider 2012a</a>). There are no systematic reviews or meta‐analyses of randomised clinical trials on this topic at present. </p> <p>Surveys of paediatric gastroenterologists indicate that they adopt different approaches to primary prophylaxis of variceal bleeding in children with portal hypertension (<a href="./references#CD011561-bbs2-0063" title="Shneider, BL. Approaches to the management of pediatric portal hypertension: results of an informal survey. In: GroszmannRJ , BoschJ , editors(s). Portal Hypertension in the 21st Century. Dordrecht, the Netherlands: Kluwer Academic Publishers, 2004:167-72.">Shneider 2004</a>; <a href="./references#CD011561-bbs2-0022" title="GanaJC , ValentinoPL , MorinvilleV , O'ConnorC , LingSC . Variation in care for children with esophageal varices: a study of physicians', patients', and families' approaches and attitudes. Journal of Pediatric Gastroenterology and Nutrition2011;52(6):751-5. [PMID: 21593647]">Gana 2011a</a>; <a href="./references#CD011561-bbs2-0073" title="Verdaguer DS , Gana AJC . [Management of pediatric patients with esophageal varices] [Enfrentamiento de pacientes pediatricos con varices esofagicas]. Revista Medica de Chile2016;144(7):879-85. [PMID: 27661550]">Verdaguer 2016</a>; <a href="./references#CD011561-bbs2-0041" title="Jeanniard-MaletO , DucheM , FabreA . Survey on clinical practice of primary prophylaxis in portal hypertension in children. Journal of Pediatric Gastroenterology and Nutrition2017;64(4):524-7. [PMID: 27801752]">Jeanniard‐Malet 2017</a>). In a survey of 30 paediatric gastroenterologists in the USA, 63% of the respondents performed surveillance of oesophageal varices and 84% offered primary prophylaxis of variceal bleeding in children (<a href="./references#CD011561-bbs2-0063" title="Shneider, BL. Approaches to the management of pediatric portal hypertension: results of an informal survey. In: GroszmannRJ , BoschJ , editors(s). Portal Hypertension in the 21st Century. Dordrecht, the Netherlands: Kluwer Academic Publishers, 2004:167-72.">Shneider 2004</a>). In a survey of 47 paediatric gastroenterologists in Canada, 70% reported that they would consider screening for oesophageal varices in children with liver disease, and evidence of cirrhosis or portal hypertension (such as splenomegaly, thrombocytopenia, or portosystemic collaterals on sonography). However, only 58% of the respondents who would screen for varices would provide primary prophylaxis (<a href="./references#CD011561-bbs2-0022" title="GanaJC , ValentinoPL , MorinvilleV , O'ConnorC , LingSC . Variation in care for children with esophageal varices: a study of physicians', patients', and families' approaches and attitudes. Journal of Pediatric Gastroenterology and Nutrition2011;52(6):751-5. [PMID: 21593647]">Gana 2011a</a>). The results of these surveys suggest that many paediatric specialists apply the guidelines for the management of adults with portal hypertension to children. However, the primary prophylaxis provided by physicians varies considerably, probably due to the lack of evidence from good‐quality randomised clinical trials. </p> <p>Different treatments have been proposed for the primary prophylaxis of oesophageal variceal bleeding in children. This systematic review is one of six reviews that examines the utility of these treatment modalities, i.e. band ligation versus sham or no intervention, for primary prophylaxis of oesophageal varices bleeding in children with chronic liver disease or portal vein thrombosis (<a href="./references#CD011561-bbs2-0078" title="GanaJC , CifuentesLI , CerdaJ , Villarroel del PinoLA , PeñaA , Rivera-CornejoM . Banding ligation versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children. Cochrane Database of Systematic Reviews2015, Issue 3. Art. No: CD011561. [DOI: 10.1002/14651858.CD011561]">Gana 2015</a>). The remaining reviews examine beta‐blockers versus placebo (<a href="./references#CD011561-bbs2-0013" title="CifuentesLI , GattiniD , Torres-RoblesR , GanaJC . Beta-blockers versus placebo or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis. Cochrane Database of Systematic Reviews2021, Issue 1. Art. No: CD011973. [DOI: 10.1002/14651858.CD011973.pub2]">Cifuentes 2021</a>), band ligation versus sclerotherapy (<a href="./references#CD011561-bbs2-0025" title="GanaJC , CifuentesLI , GattiniD , Torres-RoblesR . Band ligation versus sclerotherapy for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis. Cochrane Database of Systematic Reviews2020, Issue 11. Art. No: CD011803. [DOI: 10.1002/14651858.CD011803.pub2]">Gana 2020</a>), band ligation versus beta‐blockers (<a href="./references#CD011561-bbs2-0024" title="GanaJC , CifuentesLI , GattiniD , Villarroel Del PinoLA , PenaA , Torres-RoblesR . Band ligation versus beta-blockers for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis. Cochrane Database of Systematic Reviews2019, Issue 9. Art. No: CD010546. [DOI: 10.1002/14651858.CD010546.pub2]">Gana 2019</a>), sclerotherapy versus sham or no intervention (<a href="./references#CD011561-bbs2-0029" title="GattiniD , CifuentesLI , Torres-RoblesR , GanaJC . Sclerotherapy versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis. Cochrane Database of Systematic Reviews2020, Issue 3. Art. No: CD011573. [DOI: 10.1002/14651858.CD011573.pub2]">Gattini 2020a</a>), and sclerotherapy versus beta‐blockers (<a href="./references#CD011561-bbs2-0030" title="GattiniD , CifuentesLI , Torres-RoblesR , GanaJC . Sclerotherapy versus beta-blockers for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis. Cochrane Database of Systematic Reviews2020, Issue 1. Art. No: CD011659. [DOI: 10.1002/14651858.CD011659.pub2]">Gattini 2020b</a>) for the same target population and disease. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD011561-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD011561-sec-0014"></div> <p>To assess the benefits and harms of band ligation compared with sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD011561-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD011561-sec-0015"></div> <section id="CD011561-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD011561-sec-0017"> <h4 class="title">Types of studies</h4> <p>Randomised clinical trials, regardless of publication status, language, or blinding. The trials should have compared band ligation versus sham or no intervention, performed as primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis. </p> <p>If quasi‐randomised and observational studies were retrieved with the search results for randomised clinical trials, we planned to extract data on harm and present a narrative summary of the reported harm. This is because adverse events are rarely reported in randomised clinical trials (<a href="./references#CD011561-bbs2-0067" title="StorebøOJ , PedersenN , RamstadE , KielsholmML , NielsenSS , KroghHB , et al. Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents – assessment of adverse events in non-randomised studies. Cochrane Database of Systematic Reviews2018, Issue 5. Art. No: CD012069. [DOI: 10.1002/14651858.CD012069.pub2]">Storebø 2018</a>). Moreover, observational studies may provide information on rare or late‐occurring adverse events (<a href="./references#CD011561-bbs2-0067" title="StorebøOJ , PedersenN , RamstadE , KielsholmML , NielsenSS , KroghHB , et al. Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents – assessment of adverse events in non-randomised studies. Cochrane Database of Systematic Reviews2018, Issue 5. Art. No: CD012069. [DOI: 10.1002/14651858.CD012069.pub2]">Storebø 2018</a>). </p> </section> <section id="CD011561-sec-0018"> <h4 class="title">Types of participants</h4> <p>Children (up to 18 years old) with chronic liver disease or portal vein thrombosis, irrespective of the aetiology, severity of disease, and duration of illness, in whom the presence of oesophageal varices is confirmed by oesophagogastroduodenoscopy. The review focuses on therapy questions related to children and adolescents who have not yet suffered gastrointestinal bleeding from oesophageal varices (primary prophylaxis). </p> <p>Children with a previous surgical portal‐systemic shunt procedure or insertion of a transjugular intrahepatic portal‐systemic shunt (TIPS), previous sclerotherapy, or ligation of oesophageal varices, or previous history of upper gastrointestinal bleeding, comprise a distinct group in whom the diagnosis or natural history of oesophageal varices has been modified. These types of participants were not the focus of our review, and we excluded them unless the study report allowed us to extract only the data of relevance to our study population. </p> <p>We also planned to exclude children with previous use of beta‐blockers.</p> </section> <section id="CD011561-sec-0019"> <h4 class="title">Types of interventions</h4> <section id="CD011561-sec-0020"> <h5 class="title">Experimental</h5> <p> <ul id="CD011561-list-0001"> <li> <p>endoscopic band ligation of oesophageal varices</p> </li> </ul> </p> </section> <section id="CD011561-sec-0021"> <h5 class="title">Control</h5> <p> <ul id="CD011561-list-0002"> <li> <p>sham or no intervention</p> </li> </ul> </p> <p>Co‐interventions were allowed if administered equally to the intervention groups in a trial. </p> </section> </section> <section id="CD011561-sec-0022"> <h4 class="title">Types of outcome measures</h4> <section id="CD011561-sec-0023"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD011561-list-0003"> <li> <p>All‐cause mortality</p> </li> <li> <p>Serious adverse events and liver‐related morbidity (i.e. proportion of participants who developed ascites, hepatorenal syndrome, hepatocellular carcinoma or hepatic encephalopathy). According to the International Conference on Harmonisation (ICH) Guidelines for Good Clinical Practice (<a href="./references#CD011561-bbs2-0038" title="International Conference on Harmonisation Expert Working Group. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice CFR &amp; ICH Guidelines. Vol. 1. Philadelphia (PA): Barnett International/PAREXEL, 1997.">ICH‐GCP 1997</a>), a serious adverse event is any untoward medical occurrence that: results in death; is life‐threatening; requires inpatient hospitalisation or prolongation of existing hospitalisation; results in persistent or significant disability or incapacity; or is a congenital anomaly or birth defect. All other adverse events were considered non‐serious adverse events. </p> </li> <li> <p>Quality of life, determined exclusively by means of validated scales, classifications and measurement systems like the Paediatric Quality of Life Inventory (PedsQL), Child Health Questionnaire (CHQ), and DISABKIDS Questionnaire. </p> </li> </ul> </p> </section> <section id="CD011561-sec-0024"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD011561-list-0004"> <li> <p>Oesophageal variceal bleeding</p> </li> <li> <p>Adverse events considered not serious (any adverse events that do not meet the above criteria for serious adverse events) </p> </li> </ul> </p> <p>We planned to collect follow‐up data for the listed outcomes during the trial period, and up to five years follow‐up (the primary time point for analysis for conclusions). </p> </section> </section> </section> <section id="CD011561-sec-0025"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD011561-sec-0026"> <h4 class="title">Electronic searches</h4> <p>We searched the Cochrane Hepato‐Biliary Group Controlled Trials Register (maintained and searched internally by the Cochrane Hepato‐Biliary Group Information Specialist via the Cochrane Register of Studies Web; April 2020); Cochrane Central Register of Controlled Trials (CENTRAL; 2020, Issue 4) in The Cochrane Library (searched April 2020); PubMed (1809 to April 2020); Embase (Elsevier; 1974 to April 2020); LILACS (Latin American and Caribbean Health Science Information database; 1982 to April 2020); and Science Citation Index Expanded (Web of Science; 1900 to April 2020) (<a href="./references#CD011561-bbs2-0058" title="RoyleP , MilneR . Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches. International Journal of Technology Assessment in Health Care2003;19(4):591-603.">Royle 2003</a>). We scrutinised the reference lists of the retrieved publications. We also searched the trial registries ClinicalTrial.gov (<a href="http://clinicaltrials.gov/" target="_blank">clinicaltrials.gov/</a>), European Medicines Agency (EMA) (<a href="http://www.ema.europa.eu/ema/" target="_blank">www.ema.europa.eu/ema/</a>), World Health Organization (WHO) International Clinical Trial Registry Platform (ICTRP) (<a href="http://www.who.int/ictrp" target="_blank">www.who.int/ictrp</a>), and the Food and Drug Administration (FDA) (<a href="http://www.fda.gov" target="_blank">www.fda.gov</a>) for ongoing trials. Due to heavy traffic generated by the COVID‐19 outbreak, the ICTRP Search Portal temporarily was not accessible from outside WHO. However, trials from both ClinicalTrials.gov and the WHO trials register are included in CENTRAL. We did not limit our search by language or document type. Search strategies with the time spans of the searches are listed in <a href="./appendices#CD011561-sec-0088">Appendix 1</a>. </p> </section> <section id="CD011561-sec-0027"> <h4 class="title">Searching other resources</h4> <p>We identified additional references by handsearching the references of articles from the computerised databases and relevant review articles. Furthermore, we also performed a handsearch of the abstract books for the main paediatric gastroenterology and hepatology conferences (North American Society For Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) and European Society For Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN)) from January 2008 to December 2019. </p> </section> </section> <section id="CD011561-sec-0028"> <h3 class="title" id="CD011561-sec-0028">Data collection and analysis</h3> <p>We followed the guidelines provided in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011561-bbs2-0036" title="HigginsJP , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>)<i>.</i> The analyses were performed using Review Manager 5 (<a href="./references#CD011561-bbs2-0057" title="Nordic Cochrane Centre, The Cochrane CollaborationReview Manager (RevMan). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.">Review Manager 2014</a>). </p> <section id="CD011561-sec-0029"> <h4 class="title">Selection of studies</h4> <p>We retrieved publications if they were potentially eligible for inclusion based on an abstract review, or if they were relevant review articles for a handsearch of references. Lorena Cifuentes (LC) and Daniela Gattini (DG) independently screened the publications for eligibility. We assessed for eligibility each publication in order to determine if participants met the inclusion criteria detailed above. We planned to include abstracts only if sufficient data were provided for analysis. We considered for inclusion trials published in full, regardless of whether they reported the outcomes of interest or not. We resolved any disagreements by reaching consensus between LC, DG, and Juan Cristóbal Gana (JCG). </p> </section> <section id="CD011561-sec-0030"> <h4 class="title">Data extraction and management</h4> <p>Two authors (LC and DG) independently completed the data extraction form for the included study and retrieved the following data. </p> <p> <ul id="CD011561-list-0005"> <li> <p>General information: title, journal, year, publication status, and trial design.</p> </li> <li> <p>Sponsor of the trial.</p> </li> <li> <p>Sample size: number of participants meeting the criteria and total number screened.</p> </li> <li> <p>Baseline characteristics: baseline diagnosis, age, sex, race or ethnicity, disease severity, and concurrent medications used. </p> </li> <li> <p>Severity of liver disease of the studied population measured using the Child‐Pugh score (<a href="./references#CD011561-bbs2-0054" title="PughRN , Murray-LyonIM , DawsonJL , PietroniMC , WilliamsR . Transection of the oesophagus for bleeding oesophageal varices. British Journal of Surgery1973;60(8):646-9. [PMID: 4541913]">Pugh 1973</a>), the paediatric end‐stage liver disease (PELD) scores for children younger than 12 years (<a href="./references#CD011561-bbs2-0048" title="McDiarmidSV , AnandR , LindbladAS . Development of a pediatric end-stage liver disease score to predict poor outcome in children awaiting liver transplantation. Transplantation2002;74(2):173-81. [PMID: 12151728]">McDiarmid 2002</a>), and the model for end‐stage liver disease (MELD) scores for children aged 12 and older (<a href="./references#CD011561-bbs2-0042" title="KamathPS , WiesnerRH , MalinchocM , KremersW , TherneauTM , KosbergCL , et al. A model to predict survival in patients with end-stage liver disease. Hepatology (Baltimore, Md.)2001;33(2):464-70. [PMID: 11172350]">Kamath 2001</a>). </p> </li> <li> <p>All‐cause mortality, non‐variceal bleeding of the upper gastrointestinal tract, oesophageal variceal bleeding and quality of life determined exclusively by validated scales. </p> </li> <li> <p>Adverse events: serious and non‐serious.</p> </li> </ul> </p> <p>JCG arbitrated where there were disagreements about data extraction.</p> </section> <section id="CD011561-sec-0031"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (LC and JCG) independently assessed the risk of bias in the included trial according to the recommendations in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011561-bbs2-0036" title="HigginsJP , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>) and methodological studies (<a href="./references#CD011561-bbs2-0062" title="SchulzKF , ChalmersI , HayesRJ , AltmanDG . Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA1995;273(5):408-12.">Schulz 1995</a>; <a href="./references#CD011561-bbs2-0051" title="MoherD , PhamB , JonesA , CookDJ , JadadAR , MoherM , et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?Lancet1998;352(9128):609-13.">Moher 1998</a>; <a href="./references#CD011561-bbs2-0043" title="KjaergardLL , VillumsenJ , GluudC . Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Annals of Internal Medicine2001;135(11):982-9.">Kjaergard 2001</a>; <a href="./references#CD011561-bbs2-0077" title="WoodL , EggerM , GluudLL , SchulzKF , JüniP , AltmanGD , et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ (Clinical Research Ed.)2008;336:601-5.">Wood 2008</a>; <a href="./references#CD011561-bbs2-0059" title="SavovićJ , JonesHE , AltmanDG , HarrisRJ , JüniP , PildalJ , et al. Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Annals of Internal Medicine2012;157(6):429-38.">Savović 2012a</a>; <a href="./references#CD011561-bbs2-0060" title="SavovićJ , JonesHE , AltmanDG , HarrisRJ , JüniP , PildalJ , et al. Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Health Technology Assessment2012;16(35):1-82.">Savović 2012b</a>; <a href="./references#CD011561-bbs2-0061" title="SavovićJ , TurnerRM , MawdsleyD , JonesHE , BeynonR , HigginsJP , et al. Association between risk-of-bias assessments and results of randomized trials in Cochrane Reviews: The ROBES Meta-Epidemiologic Study. American Journal of Epidemiology2018;187(5):1113-22. [PMID: 29126260]">Savović 2018</a>). We used the following definitions in the assessment of risk of bias. </p> <section id="CD011561-sec-0032"> <h5 class="title">Allocation sequence generation</h5> <p> <ul id="CD011561-list-0006"> <li> <p>Low risk of bias: sequence generation was achieved using computer random number generation or a random number table. Drawing lots, tossing a coin, shuffling cards, and throwing dice were adequate if performed by an independent person not otherwise involved in the trial. </p> </li> <li> <p>Unclear risk of bias: the method of sequence generation was not specified.</p> </li> <li> <p>High risk of bias: the sequence generation method was not random.</p> </li> </ul> </p> </section> <section id="CD011561-sec-0033"> <h5 class="title">Allocation concealment</h5> <p> <ul id="CD011561-list-0007"> <li> <p>Low risk of bias: the participant allocations could not have been foreseen in advance of, or during, enrolment. Allocation was controlled by a central and independent randomisation unit. The allocation sequence was unknown to the investigators (e.g. if the allocation sequence was hidden in sequentially numbered, opaque, and sealed envelopes). </p> </li> <li> <p>Unclear risk of bias: the method used to conceal the allocation was not described so that intervention allocations may have been foreseen in advance of, or during, enrolment. </p> </li> <li> <p>High risk of bias: the allocation sequence was likely to be known to the investigators who assigned the participants. </p> </li> </ul> </p> </section> <section id="CD011561-sec-0034"> <h5 class="title">Blinding of participants and personnel</h5> <p> <ul id="CD011561-list-0008"> <li> <p>Low risk of bias: blinding of participants and personnel performed adequately using a placebo. We defined lack of blinding as not likely to affect the evaluation of mortality (<a href="./references#CD011561-bbs2-0059" title="SavovićJ , JonesHE , AltmanDG , HarrisRJ , JüniP , PildalJ , et al. Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Annals of Internal Medicine2012;157(6):429-38.">Savović 2012a</a>; <a href="./references#CD011561-bbs2-0060" title="SavovićJ , JonesHE , AltmanDG , HarrisRJ , JüniP , PildalJ , et al. Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Health Technology Assessment2012;16(35):1-82.">Savović 2012b</a>). </p> </li> <li> <p>Unclear risk of bias: insufficient information to assess blinding.</p> </li> <li> <p>High risk of bias: no blinding or incomplete blinding.</p> </li> </ul> </p> </section> <section id="CD011561-sec-0035"> <h5 class="title">Blinding of outcome assessors</h5> <p> <ul id="CD011561-list-0009"> <li> <p>Low risk of bias: blinding of outcome assessors performed adequately using a placebo. We defined lack of blinding as not likely to affect the evaluation of mortality (<a href="./references#CD011561-bbs2-0059" title="SavovićJ , JonesHE , AltmanDG , HarrisRJ , JüniP , PildalJ , et al. Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Annals of Internal Medicine2012;157(6):429-38.">Savović 2012a</a>; <a href="./references#CD011561-bbs2-0060" title="SavovićJ , JonesHE , AltmanDG , HarrisRJ , JüniP , PildalJ , et al. Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Health Technology Assessment2012;16(35):1-82.">Savović 2012b</a>). </p> </li> <li> <p>Unclear risk of bias: insufficient information to assess blinding.</p> </li> <li> <p>High risk of bias: no blinding or incomplete blinding.</p> </li> </ul> </p> </section> <section id="CD011561-sec-0036"> <h5 class="title">Incomplete outcome data</h5> <p> <ul id="CD011561-list-0010"> <li> <p>Low risk of bias: missing data were unlikely to make treatment effects depart from plausible values. Sufficient methods, such as multiple imputation, were employed to handle missing data. </p> </li> <li> <p>Unclear risk of bias: there was insufficient information to assess whether missing data in combination with the method used to handle missing data were likely to induce bias on the results. </p> </li> <li> <p>High risk of bias: the results were likely to be biased due to missing data.</p> </li> </ul> </p> </section> <section id="CD011561-sec-0037"> <h5 class="title">Selective outcome reporting</h5> <p> <ul id="CD011561-list-0011"> <li> <p>Low risk: the trial reported the following pre‐defined primary outcomes: 'all‐cause mortality' and 'serious adverse events and liver‐related morbidity'. If the original trial protocol was available, the outcomes should be those called for in that protocol. If the trial protocol was obtained from a trial registry (e.g. <a href="http://www.clinicaltrials.gov/" target="_blank">www.clinicaltrials.gov</a>), the outcomes sought were those enumerated in the original protocol if the trial protocol was registered before or at the time that the trial was begun. If the trial protocol was registered after the trial commenced, those outcomes were not considered to be reliable. </p> </li> <li> <p>Unclear risk: not all pre‐defined outcomes were reported fully, or it was unclear whether data on these outcomes were recorded or not. </p> </li> <li> <p>High risk: one or more pre‐defined outcomes were not reported.</p> </li> </ul> </p> </section> <section id="CD011561-sec-0038"> <h5 class="title">Other bias</h5> <p> <ul id="CD011561-list-0012"> <li> <p>Low risk of bias: the trial appeared to be free of other bias domains including vested interests that could put it at risk of bias. </p> </li> <li> <p>Unclear risk of bias: the trial may or may not have been free of other domains that could put it at risk of bias. </p> </li> <li> <p>High risk of bias: there were other factors in the trial that could put it at risk of bias </p> </li> </ul> </p> </section> <section id="CD011561-sec-0039"> <h5 class="title">Overall bias risk assessment</h5> <p> <ul id="CD011561-list-0013"> <li> <p>Low risk of bias: all domains in a trial were at low risk of bias using the definitions described above. </p> </li> <li> <p>High risk of bias: one or more of the bias domains in a trial were at unclear or high risk of bias. </p> </li> </ul> </p> </section> </section> <section id="CD011561-sec-0040"> <h4 class="title">Measures of treatment effect</h4> <section id="CD011561-sec-0041"> <h5 class="title">Dichotomous outcomes</h5> <p>For dichotomous outcomes, we calculated the risk ratio (RR) with 95% confidence intervals (CIs). We also planned to use odds ratios if the incidence of an outcome was rare (below 5%). </p> </section> <section id="CD011561-sec-0042"> <h5 class="title">Continuous outcomes</h5> <p>For continuous outcomes, we planned to calculate the mean difference (MD) with 95% CI if all trials reported quality of life using the same scale, and standardised mean difference (SMD) with 95% CI if the trials used different scales to report quality of life. </p> </section> </section> <section id="CD011561-sec-0043"> <h4 class="title">Unit of analysis issues</h4> <p>The unit of analysis was the participant undergoing treatment (i.e. primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis) according to the intervention group to which the participant was randomly assigned. In case of trials with multiple intervention groups, we planned to collect data for all trial intervention groups that met our inclusion criteria. We planned to divide the control intervention group into two to avoid double‐counting in case this was a common comparator. In the case of cross‐over trials, we planned to use the outcome data after the period of first intervention because the assigned treatments could have residual effects (<a href="./references#CD011561-bbs2-0036" title="HigginsJP , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>). Due to the clinical situation, we did not expect to find cluster‐randomised trials. </p> </section> <section id="CD011561-sec-0044"> <h4 class="title">Dealing with missing data</h4> <p>We planned to perform an intention‐to‐treat analysis whenever possible; otherwise, we planned to analyse only the data available to us and to contact the original investigators to request any missing data. We planned to address the potential impact of missing data on the findings using intention‐to‐treat analyses. </p> <p>Regarding the dichotomous primary outcomes, whenever possible, we planned to include participants with incomplete or missing data in sensitivity analyses, by imputing data according to the following scenarios. </p> <p> <ul id="CD011561-list-0014"> <li> <p>Extreme‐case analysis favouring the experimental intervention group ('best‐worse' case scenario): none of the dropouts or participants lost from the experimental group, but all of the dropouts and participants lost from the control intervention group experienced the outcome; including all randomised participants in the denominator. </p> </li> <li> <p>Extreme‐case analysis favouring the control intervention group ('worst‐best' case scenario): all dropouts or participants lost from the experimental group, but none from the control group experienced the outcome; including all randomised participants in the denominator. </p> </li> </ul> </p> <p>For the continuous primary outcome, quality of life, we planned to impute the standard deviation from P values, according to guidance in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011561-bbs2-0036" title="HigginsJP , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>; <a href="./references#CD011561-bbs2-0037" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020). The Cochrane Collaboration, 2020. Available from www.training.cochrane.org/handbook.">Higgins 2020</a>). If the data were likely to be normally distributed, we planned to use the median for meta‐analysis when the mean was not available; otherwise, we planned to provide a median and interquartile range of the difference in medians. If it was not possible to calculate the standard deviation from the P value or the CIs, we planned to impute the standard deviation using the largest standard deviation in other trials for that outcome. This form of imputation can decrease the weight of the study for calculation of MDs and may bias the effect estimate to no effect for calculation of SMDs (<a href="./references#CD011561-bbs2-0036" title="HigginsJP , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>; <a href="./references#CD011561-bbs2-0037" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020). The Cochrane Collaboration, 2020. Available from www.training.cochrane.org/handbook.">Higgins 2020</a>). </p> </section> <section id="CD011561-sec-0045"> <h4 class="title">Assessment of heterogeneity</h4> <p>We planned to identify heterogeneity by visual inspection of the forest plots, by using a standard Chi<sup>2</sup> test and a significance level of α = 0.1, in view of the low power of such tests. We planned to use the Chi<sup>2</sup> test for heterogeneity to detect between‐trial heterogeneity. In addition, we planned to specifically examine the degree of heterogeneity observed in the results with I<sup>2</sup> statistic according to the following classification: from 0% to 40%, heterogeneity may not be important; from 30% to 60%, heterogeneity may be moderate; from 50% to 90%, heterogeneity may be substantial; and from 75% to 100%, heterogeneity may be considerable (<a href="./references#CD011561-bbs2-0035" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta-analyses. BMJ (Clinical Research Ed.)2003;327(7414):557-60. [PMID: 12958120]">Higgins 2003</a>). If heterogeneity was found, we planned to determine the potential reasons for it by examining the individual trial and subgroup characteristics. </p> </section> <section id="CD011561-sec-0046"> <h4 class="title">Assessment of reporting biases</h4> <p>We planned to assess reporting biases with funnel plots of the relative risk estimates from the individual trials (plotted on a logarithmic scale) against trial size or precision (variance) or the estimators in case there were at least 10 trials. </p> </section> <section id="CD011561-sec-0047"> <h4 class="title">Data synthesis</h4> <section id="CD011561-sec-0048"> <h5 class="title">Meta‐analyses</h5> <p>We planned to conduct this systematic review according to the recommendations set out in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011561-bbs2-0036" title="HigginsJP , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>). We planned to use the statistical software Review Manager 5 provided by Cochrane to analyse data and produce summary estimates of the treatment effect (<a href="./references#CD011561-bbs2-0057" title="Nordic Cochrane Centre, The Cochrane CollaborationReview Manager (RevMan). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.">Review Manager 2014</a>). We planned to present results with a random‐effects meta‐analysis because we expected that the included trials would be heterogeneous. We planned to present results of continuous outcomes as MD or SMD, both with 95% CI. </p> <p>We planned to perform a meta‐regression to examine heterogeneity.</p> </section> </section> <section id="CD011561-sec-0049"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned to perform the following subgroup analyses because we expected that we would observe heterogeneity. </p> <p> <ul id="CD011561-list-0015"> <li> <p>Trials at low risk of bias compared to trials at high risk of bias because trials at high risk of bias may overestimate or underestimate a treatment effect (<a href="./references#CD011561-bbs2-0036" title="HigginsJP , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011</a>). </p> </li> <li> <p>Trials at risk of for‐profit bias compared to trials at no risk of for‐profit bias (post‐hoc) (<a href="./references#CD011561-bbs2-0046" title="LundhA , LexchinJ , MintzesB , SchrollJB , BeroL . Industry sponsorship and research outcome. Cochrane Database of Systematic Reviews2017, Issue 2. Art. No: MR000033. [DOI: 10.1002/14651858.MR000033.pub3]">Lundh 2017</a>). </p> </li> <li> <p>Primary prophylaxis of small varices compared to primary prophylaxis of only medium or large varices because of the different risk of bleeding according to the variceal size (<a href="./references#CD011561-bbs2-0028" title="Garcia-TsaoG , AbraldesJG , BerzigottiA , BoschJ . Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology (Baltimore, Md.)2017;65(1):310-35. [PMID: 27786365]">Garcia‐Tsao 2017</a>). </p> </li> <li> <p>Children with chronic liver disease compared to children with extrahepatic portal vein thrombosis because of the differences in the physiopathology of the cause of the portal hypertension in patients with liver disease versus alteration in the portal inflow (<a href="./references#CD011561-bbs2-0012" title="ChapinCA , BassLM . Cirrhosis and portal hypertension in the pediatric population. Clinics in Liver Disease2018;22(4):735-52. [PMID: 30266160]">Chapin 2018</a>). </p> </li> <li> <p>Severity of liver disease (Child‐Pugh A, B, or C, and PELD or MELD) because of the different risk of bleeding according to the impaired liver function (<a href="./references#CD011561-bbs2-0028" title="Garcia-TsaoG , AbraldesJG , BerzigottiA , BoschJ . Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology (Baltimore, Md.)2017;65(1):310-35. [PMID: 27786365]">Garcia‐Tsao 2017</a>). </p> </li> <li> <p>Children with cholestatic liver disease compared to children with non‐cholestatic liver disease because of the different risk of bleeding according to different etiologies (<a href="./references#CD011561-bbs2-0012" title="ChapinCA , BassLM . Cirrhosis and portal hypertension in the pediatric population. Clinics in Liver Disease2018;22(4):735-52. [PMID: 30266160]">Chapin 2018</a>). </p> </li> </ul> </p> </section> <section id="CD011561-sec-0050"> <h4 class="title">Sensitivity analysis</h4> <p>In addition to the sensitivity analyses specified under '<a href="#CD011561-sec-0044">Dealing with missing data</a>', in order to assess the robustness of the eligibility criteria, our intention was to undertake further sensitivity analyses that might be able to explain our findings as well as any observed heterogeneity. </p> <section id="CD011561-sec-0051"> <h5 class="title">Trial Sequential Analysis</h5> <p>We planned to perform Trial Sequential Analysis (<a href="./references#CD011561-bbs2-0070" title="Copenhagen Trial UnitTSA - Trial Sequential Analysis. Version 0.9.5.10 Beta. Copenhagen: Copenhagen Trial Unit, 2011. www.ctu.dk/tsa/downloads.aspx.">TSA 2011</a>; <a href="./references#CD011561-bbs2-0069" title="ThorlundK , EngstrømJ , WetterslevJ , BrokJ , ImbergerG , GluudC . User manual for Trial Sequential Analysis (TSA). https://ctu.dk/wp-content/uploads/2020/12/tsa_manual_ENG.pdf 2017 (accessed 13 January 2021).">Thorlund 2017</a>) because cumulative meta‐analyses are at risk of producing random errors due to sparse data and repetitive testing of the accumulating data (<a href="./references#CD011561-bbs2-0074" title="WetterslevJ , ThorlundK , BrokJ , GluudC . Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. Journal of Clinical Epidemiology2008;61(1):64-75.">Wetterslev 2008</a>). To minimise random errors, we planned to calculate the required information size (i.e. the number of children needed in a meta‐analysis to detect or reject a certain intervention effect) (<a href="./references#CD011561-bbs2-0074" title="WetterslevJ , ThorlundK , BrokJ , GluudC . Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. Journal of Clinical Epidemiology2008;61(1):64-75.">Wetterslev 2008</a>). </p> <p>The required information size calculation should also account for the heterogeneity or diversity present in the meta‐analysis (<a href="./references#CD011561-bbs2-0074" title="WetterslevJ , ThorlundK , BrokJ , GluudC . Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. Journal of Clinical Epidemiology2008;61(1):64-75.">Wetterslev 2008</a>; <a href="./references#CD011561-bbs2-0075" title="WetterslevJ , ThorlundK , BrokJ , GluudC . Estimating required information size by quantifying diversity in a random-effects meta-analysis. BMC Medical Research Methodology2009;9:86.">Wetterslev 2009</a>; <a href="./references#CD011561-bbs2-0076" title="WetterslevJ , JakobsenJC , GluudC . Trial Sequential Analysis in systematic reviews with meta-analysis. BMC Medical Research Methodology2017;17(1):39.">Wetterslev 2017</a>). In our meta‐analyses, we planned to base the diversity‐adjusted required information size (DARIS) on: the event proportion in the control group; assumption of a plausible relative risk reduction of 20% or the relative risk reduction observed in the included trials with low risk of bias; a risk of type I error of 2.5% because of three primary outcomes and 3.3% because of two secondary outcomes; a risk of type II error of 20%; and the observed diversity of the meta‐analysis (<a href="./references#CD011561-bbs2-0075" title="WetterslevJ , ThorlundK , BrokJ , GluudC . Estimating required information size by quantifying diversity in a random-effects meta-analysis. BMC Medical Research Methodology2009;9:86.">Wetterslev 2009</a>; <a href="./references#CD011561-bbs2-0040" title="JakobsenJ , WetterslevJ , WinkelP , LangeT , GluudC . Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods. BMC Medical Research Methodology2014;14:120.">Jakobsen 2014</a>; <a href="./references#CD011561-bbs2-0076" title="WetterslevJ , JakobsenJC , GluudC . Trial Sequential Analysis in systematic reviews with meta-analysis. BMC Medical Research Methodology2017;17(1):39.">Wetterslev 2017</a>). </p> <p>The underlying assumption of Trial Sequential Analysis is that testing for significance may be performed each time a new trial is added to the meta‐analysis. We planned to add the trials according to the year of publication, and, if more than one trial was published in a year, we planned to add trials alphabetically by last name of the first author. Based on the DARIS, we planned to construct trial sequential monitoring boundaries (<a href="./references#CD011561-bbs2-0074" title="WetterslevJ , ThorlundK , BrokJ , GluudC . Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. Journal of Clinical Epidemiology2008;61(1):64-75.">Wetterslev 2008</a>; <a href="./references#CD011561-bbs2-0069" title="ThorlundK , EngstrømJ , WetterslevJ , BrokJ , ImbergerG , GluudC . User manual for Trial Sequential Analysis (TSA). https://ctu.dk/wp-content/uploads/2020/12/tsa_manual_ENG.pdf 2017 (accessed 13 January 2021).">Thorlund 2017</a>; <a href="./references#CD011561-bbs2-0076" title="WetterslevJ , JakobsenJC , GluudC . Trial Sequential Analysis in systematic reviews with meta-analysis. BMC Medical Research Methodology2017;17(1):39.">Wetterslev 2017</a>). These boundaries determine the statistical inference one may draw regarding the cumulative meta‐analysis that has not reached the required information size. If the trial sequential monitoring boundary for benefit or harm is crossed before the required information size is reached, firm evidence may be established and further trials may be superfluous. However, if the boundary is not crossed, it is probably necessary to continue conducting trials in order to detect or reject a certain intervention effect. This can be determined by assessing if the cumulative Z‐curve crosses the trial sequential monitoring boundaries for futility. </p> <p>We planned to downgrade our assessment for imprecision in Trial Sequential Analysis by two levels if the accrued number of participants was below 50% of the DARIS, and one level if the number was between 50% and 100% of DARIS. We planned to not downgrade our assessment of imprecision if the cumulative Z‐curve reached futility or DARIS. </p> </section> </section> <section id="CD011561-sec-0052"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We created a 'Summary of findings' table, using GRADEpro (<a href="./references#CD011561-bbs2-0034" title="McMaster University (developed by Evidence Prime)GRADEpro GDT. Version accessed 4 May 2020. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015. Available at gradepro.org.">GRADEpro GDT</a>), to provide information about the certainty of the evidence, the magnitude of effects of the interventions, and to summarise results on outcomes of all‐cause mortality, serious adverse events and liver‐related morbidity, quality of life, oesophageal bleeding, and non‐serious adverse events. </p> <p>The GRADE approach appraises the certainty of a body of evidence based on the extent to which one can be confident that an estimate of effect or association reflects the item being assessed. The certainty of a body of evidence considers: within‐study risk of bias; indirectness of the evidence (population, intervention, control, outcomes); unexplained inconsistency (heterogeneity) of results (including problems with subgroup analyses); imprecision of results; and risk of publication bias. </p> <p>We classify the levels of evidence as 'high', 'moderate', 'low', or 'very low'. These grades are defined as follows: </p> <p> <ul id="CD011561-list-0016"> <li> <p><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect. </p> </li> <li> <p><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. </p> </li> <li> <p><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect. </p> </li> <li> <p><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </li> </ul> </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD011561-sec-0053" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD011561-sec-0053"></div> <section id="CD011561-sec-0054"> <h3 class="title">Description of studies</h3> <section id="CD011561-sec-0055"> <h4 class="title">Results of the search</h4> <p>We identified 870 records in the initial electronic search for interventions for primary prophylaxis of oesophageal variceal bleeding in children or adolescents. We identified four additional records through handsearching the ESPGHAN and NASPGHAN conference abstract books from 2008 through 2019. After excluding duplicates, we found a total of 642 records. For this systematic review, in which band ligation is compared with sham or no intervention, we identified 98 records for abstract review. We excluded 89 of them because they did not meet the criteria for inclusion in this review (<a href="#CD011561-fig-0001">Figure 1</a>). We assessed a total of nine full‐text publications for eligibility and for reports on harm. We excluded eight of these publications because they included adults, assessed secondary prophylaxis, or involved a different intervention (<a href="#CD011561-fig-0001">Figure 1</a>). However, two of the eight publications reported on harm. The remaining one publication, a conference abstract, met our inclusion criteria (<a href="./references#CD011561-bbs2-0001" title="McKiernanPJ , Van MourikID , DhawanA , GrammatikopoulosT , DavenportM , DavisonSM , et al. A multicentre randomised controlled pilot trial of variceal band ligation for primary prophylaxis of oesophageal variceal bleeding in childhood portal hypertension. Journal of Pediatric Gastroenterology and Nutrition2011;52:E189-90. ">McKiernan 2011</a>). </p> <div class="figure" id="CD011561-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram. Date of search 27 April 2020." data-id="CD011561-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011561.pub2/media/CDSR/CD011561/image_n/nCD011561-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram. Date of search 27 April 2020.</p> </div> </div> </div> <p>We did not find any ongoing clinical trials assessing band ligation versus sham or no intervention for primary prophylaxis of variceal bleeding in children and adolescents. </p> </section> <section id="CD011561-sec-0056"> <h4 class="title">Included studies</h4> <p>The conference abstract described a multi‐centre feasibility randomised clinical trial in children (<a href="./references#CD011561-bbs2-0001" title="McKiernanPJ , Van MourikID , DhawanA , GrammatikopoulosT , DavenportM , DavisonSM , et al. A multicentre randomised controlled pilot trial of variceal band ligation for primary prophylaxis of oesophageal variceal bleeding in childhood portal hypertension. Journal of Pediatric Gastroenterology and Nutrition2011;52:E189-90. ">McKiernan 2011</a>). The trial was not subsequently published as a full text. The trial involved three hospital centres in the United Kingdom (UK). Sixty‐five children with portal hypertension but without previous history of gastrointestinal bleeding or beta‐blocker treatment were recruited prior to routine endoscopy. Of these, 22 children had large oesophageal varices and were randomised to receive either prophylactic band ligation (12 children) versus no active intervention (10 children). There was no information about how any of the participants were diagnosed. All children were followed for at least six months. Two children were lost to follow‐up by one‐year. Ten children in total completed the trial at two‐year follow‐up. The abstract contained no information on trial funding. </p> <p>We did not find any other trial fulfilling the inclusion criteria of our review.</p> </section> <section id="CD011561-sec-0057"> <h4 class="title">Excluded studies</h4> <p>The eight excluded studies are listed in <a href="./references#CD011561-sec-0098" title="">Characteristics of excluded studies</a> with the reasons for exclusion. </p> </section> </section> <section id="CD011561-sec-0058"> <h3 class="title">Risk of bias in included studies</h3> <p>The only included trial was at an overall high risk of bias: all bias domains were either at high risk of bias or unclear risk of bias (<a href="#CD011561-fig-0002">Figure 2</a>; <a href="#CD011561-fig-0003">Figure 3</a>). </p> <div class="figure" id="CD011561-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD011561-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011561.pub2/media/CDSR/CD011561/image_n/nCD011561-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD011561-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD011561-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011561.pub2/media/CDSR/CD011561/image_n/nCD011561-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD011561-sec-0059"> <h4 class="title">Allocation</h4> <p>Unclear risk of bias: the method of sequence generation and allocation concealment were not specified. </p> </section> <section id="CD011561-sec-0060"> <h4 class="title">Blinding</h4> <p>High risk of bias: it is very likely that blinding of the children and the clinicians treating them was not possible as the control group received no active intervention, making this domain at high risk of bias. </p> </section> <section id="CD011561-sec-0061"> <h4 class="title">Incomplete outcome data</h4> <p>Unclear risk of bias: there was insufficient information to assess whether missing data in combination with the method used to handle missing data were likely to induce bias on the results. </p> </section> <section id="CD011561-sec-0062"> <h4 class="title">Selective reporting</h4> <p>Unclear risk: not all pre‐defined outcomes were reported fully, or it was unclear whether data on these outcomes were recorded or not. </p> </section> <section id="CD011561-sec-0063"> <h4 class="title">Other potential sources of bias</h4> <p>Unclear risk of bias: the trial may or may not have been free of other domains that could put it at risk of bias. </p> </section> </section> <section id="CD011561-sec-0064"> <h3 class="title" id="CD011561-sec-0064">Effects of interventions</h3> <p>See: <a href="./full#CD011561-tbl-0001"><b>Summary of findings 1</b> Band ligation compared to sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis</a> </p> <p>We calculated point estimates with relative risks, using RevMan analysis. We entered data based on the intention‐to‐treat principle. We did not use odds ratios as the events were higher than 5%. </p> <section id="CD011561-sec-0065"> <h4 class="title">Primary outcomes</h4> <section id="CD011561-sec-0066"> <h5 class="title">All‐cause mortality</h5> <p>All‐cause mortality was 8% (1/12) in the band ligation group versus 0% (0/10) in the no active intervention group (RR 2.54, 95% CI 0.11 to 56.25; very low‐certainty of evidence; <a href="./references#CD011561-fig-0004" title="">Analysis 1.1</a>). </p> </section> <section id="CD011561-sec-0067"> <h5 class="title">Serious adverse events and liver‐related morbidity</h5> <p>None of the 12 children (0%) in the band ligation group developed serious adverse events, while one child out of 10 (10%) in the no active intervention group developed a serious adverse event (RR 0.28, 95% CI 0.01 to 6.25; very low‐certainty of evidence; <a href="./references#CD011561-fig-0005" title="">Analysis 1.2</a>; <a href="./full#CD011561-tbl-0001">summary of findings Table 1</a>). That child developed idiopathic thrombocytopaenic purpura. </p> <p>One child out of 12 (8%) in the band ligation group underwent liver transplantation, versus none in the no active intervention group (0%) (RR 2.54, 95% CI 0.11 to 56.25; very low‐certainty of evidence; <a href="./references#CD011561-fig-0005" title="">Analysis 1.2</a>; <a href="./full#CD011561-tbl-0001">summary of findings Table 1</a>). </p> <p>No other serious adverse events were reported in either group.</p> </section> <section id="CD011561-sec-0068"> <h5 class="title">Quality of life</h5> <p>The trial reported no data on quality of life.</p> </section> </section> <section id="CD011561-sec-0069"> <h4 class="title">Secondary outcomes</h4> <section id="CD011561-sec-0070"> <h5 class="title">Oesophageal variceal bleeding</h5> <p>Oesophageal variceal bleeding occurred in 8% (1/12) of the children in the band ligation group versus 30% (3/10) of the children in the no active intervention group (RR 0.28, 95% CI 0.03 to 2.27; very low‐certainty of evidence; <a href="./references#CD011561-fig-0006" title="">Analysis 1.3</a>; <a href="./full#CD011561-tbl-0001">summary of findings Table 1</a>). </p> </section> <section id="CD011561-sec-0071"> <h5 class="title">Adverse events considered not serious</h5> <p>Adverse events considered non‐serious were not reported.</p> </section> </section> <section id="CD011561-sec-0072"> <h4 class="title">Subgroup analysis</h4> <p>Due to the inclusion of one trial only, we could not perform any of the subgroup analyses.</p> </section> <section id="CD011561-sec-0073"> <h4 class="title">Sensitivity analysis</h4> <p>We decided not to perform the two scenario analyses described in Dealing with missing data because there is only one included trial assessed at overall high risk of bias, and the certainty of the evidence is very low. We cannot be sure whether the two children who were lost to follow‐up continued to contribute outcome data. </p> <p>We did not perform Trial Sequential Analysis because only one trial was included.</p> </section> <section id="CD011561-sec-0074"> <h4 class="title">Harms observed in observational studies, retrieved with the searches for randomised trials </h4> <p>Two of the eight excluded studies disclosed information on harm (<a href="./references#CD011561-bbs2-0002" title="Celinska-CedroD , TeisseyreM , WoynarowskiM , SochaP , SochaJ , RyzkoJ . Endoscopic ligation of esophageal varices for prophylaxis of first bleeding in children and adolescents with portal hypertension: preliminary results of a prospective study. Journal of Pediatric Surgery2003;38(7):1008-11. [PMID: 12861528]">Celinska‐Cedro 2003</a>; <a href="./references#CD011561-bbs2-0004" title="GalandJ , LeyD , CoopmanS , MichaudL , GuimberD , TurckD , et al. Primary prophylaxis of oesophageal variceal bleeding in children by ligation is safe and as efficient as secondary prophylaxis. Journal of Hepatology2018;68(3):600-1. [PMID: 28958884]">Galand 2018</a>; <a href="#CD011561-tbl-0002">Table 1</a>).  </p> <div class="table" id="CD011561-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Harms reported in observational studies</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Short summary</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Report on harms</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011561-bbs2-0002" title="Celinska-CedroD , TeisseyreM , WoynarowskiM , SochaP , SochaJ , RyzkoJ . Endoscopic ligation of esophageal varices for prophylaxis of first bleeding in children and adolescents with portal hypertension: preliminary results of a prospective study. Journal of Pediatric Surgery2003;38(7):1008-11. [PMID: 12861528]">Celinska‐Cedro 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The study assessed primary prophylaxis with endoscopic variceal ligation in 37 children with portal hypertension (22 with liver cirrhosis and 15 with portal vein thrombosis). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐ No variceal bleeding occurred during the study period.</p> <p>‐ No serious adverse events of variceal ligation were reported.</p> <p>The average follow‐up time was 16 months.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011561-bbs2-0004" title="GalandJ , LeyD , CoopmanS , MichaudL , GuimberD , TurckD , et al. Primary prophylaxis of oesophageal variceal bleeding in children by ligation is safe and as efficient as secondary prophylaxis. Journal of Hepatology2018;68(3):600-1. [PMID: 28958884]">Galand 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The study assessed primary prophylaxis of digestive haemorrhage by oesophageal variceal ligation in comparison to secondary prophylaxis. </p> <p>30 children were included in the primary prophylaxis group (median age 7.7 years, range 1.2 to 18 years), and 15 in the secondary prophylaxis group (median age 4.7 years, range 1.5 to 14 years). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐ 2 children had adverse events associated with endoscopic band ligation prophylaxis: <i>Enterobacter cloacae</i> septicaemia (n = 1) and mild transient upper oesophageal sphincter stenosis (n = 1) </p> </td> </tr> </tbody> </table> </div> <p>We did not assess risk of bias in the observational studies as this was not planned.</p> </section> <section id="CD011561-sec-0075"> <h4 class="title">'Summary of findings' tables</h4> <p>We downgraded the certainty of evidence to very low because of 'within‐trial risk of bias', 'indirectness', and 'imprecision' for the following outcomes: all‐cause mortality; serious adverse events and liver‐related morbidity; and oesophageal variceal bleeding. We could not GRADE the evidence for non‐serious adverse events because no adverse events were reported. Health‐related quality of life was not reported as an outcome (See <a href="./full#CD011561-tbl-0001">summary of findings Table 1</a>). </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD011561-sec-0076" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD011561-sec-0076"></div> <section id="CD011561-sec-0077"> <h3 class="title" id="CD011561-sec-0077">Summary of main results</h3> <p>After performing a systematic review of the literature, we found only one abstract describing a paediatric multi‐centre feasibility randomised clinical trial on primary prophylaxis of band ligation versus no active intervention in 22 children with portal hypertension and large oesophageal varices (<a href="./references#CD011561-bbs2-0001" title="McKiernanPJ , Van MourikID , DhawanA , GrammatikopoulosT , DavenportM , DavisonSM , et al. A multicentre randomised controlled pilot trial of variceal band ligation for primary prophylaxis of oesophageal variceal bleeding in childhood portal hypertension. Journal of Pediatric Gastroenterology and Nutrition2011;52:E189-90. ">McKiernan 2011</a>). There was no information about how any of the participants were diagnosed. The trial was at high risk of bias (<a href="#CD011561-fig-0003">Figure 3</a>), and the certainty of evidence is very low. Therefore, we are very uncertain whether prophylactic band ligation increases mortality, leads to serious adverse events and liver‐related morbidity, or decreases oesophageal variceal bleeding in children with portal hypertension and large oesophageal varices. The trial abstract did not report non‐serious adverse events related to the intervention. The trial did not include upper gastrointestinal bleeding and quality of life as outcomes. The abstract reported no information on trial funding, and the trial was not subsequently published as a full text. We did not find any other randomised clinical trials for inclusion in this review. Trial data on children with portal vein thrombosis are lacking. </p> </section> <section id="CD011561-sec-0078"> <h3 class="title" id="CD011561-sec-0078">Overall completeness and applicability of evidence</h3> <p>In adults, primary prophylaxis of bleeding varices with variceal band ligation or beta‐blockers is the standard management for people with chronic liver disease and portal hypertension (<a href="./references#CD011561-bbs2-0028" title="Garcia-TsaoG , AbraldesJG , BerzigottiA , BoschJ . Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology (Baltimore, Md.)2017;65(1):310-35. [PMID: 27786365]">Garcia‐Tsao 2017</a>). However, there are currently no evidence‐based recommendations for the prophylactic management of children or adolescents at risk of oesophageal variceal bleeding. This is due to a lack of randomised clinical trials (<a href="./references#CD011561-bbs2-0066" title="ShneiderBL , deVille de GoyetJ , LeungDH , SrivastavaA , LingSC , DucheM , et al. Primary prophylaxis of variceal bleeding in children and the role of MesoRex Bypass: summary of the Baveno VI Pediatric Satellite Symposium. Hepatology (Baltimore, Md.)2016;63(4):1368-80. [PMID: 26358549]">Shneider 2016</a>).  </p> <p>Surveys of paediatric gastroenterologists regarding their use of primary prophylaxis for variceal bleeding in children have shown that they adopt different approaches to the management of children with portal hypertension (<a href="./references#CD011561-bbs2-0063" title="Shneider, BL. Approaches to the management of pediatric portal hypertension: results of an informal survey. In: GroszmannRJ , BoschJ , editors(s). Portal Hypertension in the 21st Century. Dordrecht, the Netherlands: Kluwer Academic Publishers, 2004:167-72.">Shneider 2004</a>; <a href="./references#CD011561-bbs2-0022" title="GanaJC , ValentinoPL , MorinvilleV , O'ConnorC , LingSC . Variation in care for children with esophageal varices: a study of physicians', patients', and families' approaches and attitudes. Journal of Pediatric Gastroenterology and Nutrition2011;52(6):751-5. [PMID: 21593647]">Gana 2011a</a>; <a href="./references#CD011561-bbs2-0073" title="Verdaguer DS , Gana AJC . [Management of pediatric patients with esophageal varices] [Enfrentamiento de pacientes pediatricos con varices esofagicas]. Revista Medica de Chile2016;144(7):879-85. [PMID: 27661550]">Verdaguer 2016</a>; <a href="./references#CD011561-bbs2-0041" title="Jeanniard-MaletO , DucheM , FabreA . Survey on clinical practice of primary prophylaxis in portal hypertension in children. Journal of Pediatric Gastroenterology and Nutrition2017;64(4):524-7. [PMID: 27801752]">Jeanniard‐Malet 2017</a>). This suggests that many paediatric specialists apply the guidelines for management of adults with portal hypertension to children.   </p> <p>One possible limitation on conducting randomised clinical trials is the small number of children with portal hypertension compared to adults. However, multi‐centre randomised clinical trials could be conducted. The authors of the included feasibility trial in our review concluded that it was possible to recruit children with portal hypertension for a larger study of primary prophylaxis since prophylactic variceal band ligation was "well tolerated" (<a href="./references#CD011561-bbs2-0001" title="McKiernanPJ , Van MourikID , DhawanA , GrammatikopoulosT , DavenportM , DavisonSM , et al. A multicentre randomised controlled pilot trial of variceal band ligation for primary prophylaxis of oesophageal variceal bleeding in childhood portal hypertension. Journal of Pediatric Gastroenterology and Nutrition2011;52:E189-90. ">McKiernan 2011</a>). We may, therefore, assume the trial authors meant that band ligation may benefit patients. </p> <p>Different treatments have been proposed for the primary prophylaxis of oesophageal variceal bleeding. This systematic review is one of six reviews that examines the utility of these treatments modalities (<a href="./references#CD011561-bbs2-0025" title="GanaJC , CifuentesLI , GattiniD , Torres-RoblesR . Band ligation versus sclerotherapy for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis. Cochrane Database of Systematic Reviews2020, Issue 11. Art. No: CD011803. [DOI: 10.1002/14651858.CD011803.pub2]">Gana 2020</a>; <a href="./references#CD011561-bbs2-0024" title="GanaJC , CifuentesLI , GattiniD , Villarroel Del PinoLA , PenaA , Torres-RoblesR . Band ligation versus beta-blockers for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis. Cochrane Database of Systematic Reviews2019, Issue 9. Art. No: CD010546. [DOI: 10.1002/14651858.CD010546.pub2]">Gana 2019</a>; <a href="./references#CD011561-bbs2-0029" title="GattiniD , CifuentesLI , Torres-RoblesR , GanaJC . Sclerotherapy versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis. Cochrane Database of Systematic Reviews2020, Issue 3. Art. No: CD011573. [DOI: 10.1002/14651858.CD011573.pub2]">Gattini 2020a</a>; <a href="./references#CD011561-bbs2-0030" title="GattiniD , CifuentesLI , Torres-RoblesR , GanaJC . Sclerotherapy versus beta-blockers for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis. Cochrane Database of Systematic Reviews2020, Issue 1. Art. No: CD011659. [DOI: 10.1002/14651858.CD011659.pub2]">Gattini 2020b</a>; <a href="./references#CD011561-bbs2-0013" title="CifuentesLI , GattiniD , Torres-RoblesR , GanaJC . Beta-blockers versus placebo or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis. Cochrane Database of Systematic Reviews2021, Issue 1. Art. No: CD011973. [DOI: 10.1002/14651858.CD011973.pub2]">Cifuentes 2021</a>). </p> </section> <section id="CD011561-sec-0079"> <h3 class="title" id="CD011561-sec-0079">Quality of the evidence</h3> <p>Following the GRADE Working Group grades of evidence, we assessed the measured outcomes in the trial as very low‐certainty evidence, meaning that our confidence in the effect estimate is limited and the true effect may be substantially different from the estimate of the effect. We found no other randomised clinical trials. </p> </section> <section id="CD011561-sec-0080"> <h3 class="title" id="CD011561-sec-0080">Potential biases in the review process</h3> <p>We could not identify any potential bias in the review process. We could not do a funnel plot to assess for possible publication bias since only one trial published as a conference abstract was included. </p> </section> <section id="CD011561-sec-0081"> <h3 class="title" id="CD011561-sec-0081">Agreements and disagreements with other studies or reviews</h3> <p>We found no reviews prepared by other authors on the subject. Other reviews in our suite of reviews compared band ligation versus beta‐blockers (<a href="./references#CD011561-bbs2-0024" title="GanaJC , CifuentesLI , GattiniD , Villarroel Del PinoLA , PenaA , Torres-RoblesR . Band ligation versus beta-blockers for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis. Cochrane Database of Systematic Reviews2019, Issue 9. Art. No: CD010546. [DOI: 10.1002/14651858.CD010546.pub2]">Gana 2019</a>); band ligation versus sclerotherapy (<a href="./references#CD011561-bbs2-0025" title="GanaJC , CifuentesLI , GattiniD , Torres-RoblesR . Band ligation versus sclerotherapy for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis. Cochrane Database of Systematic Reviews2020, Issue 11. Art. No: CD011803. [DOI: 10.1002/14651858.CD011803.pub2]">Gana 2020</a>); sclerotherapy versus sham or no intervention (<a href="./references#CD011561-bbs2-0029" title="GattiniD , CifuentesLI , Torres-RoblesR , GanaJC . Sclerotherapy versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis. Cochrane Database of Systematic Reviews2020, Issue 3. Art. No: CD011573. [DOI: 10.1002/14651858.CD011573.pub2]">Gattini 2020a</a>); sclerotherapy versus beta‐blockers (<a href="./references#CD011561-bbs2-0030" title="GattiniD , CifuentesLI , Torres-RoblesR , GanaJC . Sclerotherapy versus beta-blockers for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis. Cochrane Database of Systematic Reviews2020, Issue 1. Art. No: CD011659. [DOI: 10.1002/14651858.CD011659.pub2]">Gattini 2020b</a>); and beta‐blockers versus placebo (<a href="./references#CD011561-bbs2-0013" title="CifuentesLI , GattiniD , Torres-RoblesR , GanaJC . Beta-blockers versus placebo or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis. Cochrane Database of Systematic Reviews2021, Issue 1. Art. No: CD011973. [DOI: 10.1002/14651858.CD011973.pub2]">Cifuentes 2021</a>). The <a href="./references#CD011561-bbs2-0029" title="GattiniD , CifuentesLI , Torres-RoblesR , GanaJC . Sclerotherapy versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis. Cochrane Database of Systematic Reviews2020, Issue 3. Art. No: CD011573. [DOI: 10.1002/14651858.CD011573.pub2]">Gattini 2020a</a>  review comparing sclerotherapy versus sham or no intervention contains one randomised clinical trial (<a href="./references#CD011561-bbs2-0033" title="Gonçalves ME , Cardoso SR, MaksoudJG . Prophylactic sclerotherapy in children with esophageal varices: long-term results of a controlled prospective randomized trial. Journal of Pediatric Surgery2000;35(3):401-5. [PMID: 12960256]">Gonçalves 2000</a>). However, this is insufficient for the purpose of comparing and discussing results. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD011561-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011561.pub2/media/CDSR/CD011561/urn:x-wiley:14651858:media:CD011561:CD011561-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram. Date of search 27 April 2020." data-id="CD011561-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011561.pub2/media/CDSR/CD011561/image_n/nCD011561-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011561.pub2/media/CDSR/CD011561/image_t/tCD011561-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram. Date of search 27 April 2020.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011561.pub2/full#CD011561-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011561.pub2/media/CDSR/CD011561/image_n/nCD011561-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011561-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011561.pub2/media/CDSR/CD011561/urn:x-wiley:14651858:media:CD011561:CD011561-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD011561-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011561.pub2/media/CDSR/CD011561/image_n/nCD011561-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011561.pub2/media/CDSR/CD011561/image_t/tCD011561-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011561.pub2/full#CD011561-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011561.pub2/media/CDSR/CD011561/image_n/nCD011561-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011561-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011561.pub2/media/CDSR/CD011561/urn:x-wiley:14651858:media:CD011561:CD011561-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD011561-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011561.pub2/media/CDSR/CD011561/image_n/nCD011561-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011561.pub2/media/CDSR/CD011561/image_t/tCD011561-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011561.pub2/full#CD011561-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011561.pub2/media/CDSR/CD011561/image_n/nCD011561-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011561-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011561.pub2/media/CDSR/CD011561/urn:x-wiley:14651858:media:CD011561:CD011561-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Band ligation versus sham or no intervention, Outcome 1: All‐cause mortality" data-id="CD011561-fig-0004" src="/cdsr/doi/10.1002/14651858.CD011561.pub2/media/CDSR/CD011561/image_n/nCD011561-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011561.pub2/media/CDSR/CD011561/image_t/tCD011561-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Band ligation versus sham or no intervention, Outcome 1: All‐cause mortality</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011561.pub2/references#CD011561-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011561.pub2/media/CDSR/CD011561/image_n/nCD011561-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011561-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011561.pub2/media/CDSR/CD011561/urn:x-wiley:14651858:media:CD011561:CD011561-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Band ligation versus sham or no intervention, Outcome 2: Serious adverse events and liver‐related morbidity" data-id="CD011561-fig-0005" src="/cdsr/doi/10.1002/14651858.CD011561.pub2/media/CDSR/CD011561/image_n/nCD011561-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011561.pub2/media/CDSR/CD011561/image_t/tCD011561-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Band ligation versus sham or no intervention, Outcome 2: Serious adverse events and liver‐related morbidity </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011561.pub2/references#CD011561-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011561.pub2/media/CDSR/CD011561/image_n/nCD011561-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011561-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011561.pub2/media/CDSR/CD011561/urn:x-wiley:14651858:media:CD011561:CD011561-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Band ligation versus sham or no intervention, Outcome 3: Oesophageal variceal bleeding" data-id="CD011561-fig-0006" src="/cdsr/doi/10.1002/14651858.CD011561.pub2/media/CDSR/CD011561/image_n/nCD011561-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011561.pub2/media/CDSR/CD011561/image_t/tCD011561-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Band ligation versus sham or no intervention, Outcome 3: Oesophageal variceal bleeding </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011561.pub2/references#CD011561-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011561.pub2/media/CDSR/CD011561/image_n/nCD011561-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD011561-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Band ligation compared to sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Band ligation versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> children with portal hypertension and large oesophageal varices, without previous gastrointestinal bleeding or beta‐blocker treatment<br/><b>Setting:</b> pilot study in three hospital centres in United Kingdom<br/><b>Intervention:</b> band ligation<br/><b>Comparison: </b>no active treatment </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(trials)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with sham or no intervention</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with band ligation</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All‐cause mortality<br/>Follow‐up: </p> <p>at minimum 6 months*</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1,000<br/>(0 to 0 ) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 2.54<br/>(0.11 to 56.25) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊝⊝⊝⊝<br/>Very low <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All‐cause mortality was 8% (1/12) in the band ligation group and 0% (0/10) in the no active intervention group </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Serious adverse events</p> <p>Idiopathic thrombocytopaenic purpura</p> <p>Follow‐up: at minimum 6 months*</p> <p>and</p> <p>Liver‐related morbidity:</p> <p>‐ liver transplantation<br/>Follow‐up: at minimum 6 months* </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>100 per 1,000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>28 per 1,000<br/>(1 to 625) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.28 (0.01 to 6.25)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝</p> <p>Very low <sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 out of 12 children (0%) in the band ligation group developed idiopathic thrombocytopaenic purpura versus 1 out of 10 (10%) in the no active intervention group. </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1,000<br/>( 0 to 0) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 2.54<br/>(0.11 to 56.25) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝</p> <p>Very low <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1/12 children (8%) randomised to band ligation underwent liver transplantation while 0/10 children (0%) in the no active intervention group underwent liver transplantation </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Health‐related quality of life</p> </td> <td align="" class="table-tint table-highlight" colspan="5" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Outcome not assessed in the trial</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oesophageal variceal bleeding<br/>Follow‐up: at minimum 6 months* </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>300 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>84 per 1,000<br/>(9 to 681) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.28<br/>(0.03 to 2.27) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>22<br/>(1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/>Very low <sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oesophageal variceal bleeding occurred in 8% (1/12) of the children in the band ligation group and in 30% (3/10) of the children in the no active intervention group. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse events considered</p> <p>not serious</p> <p>Follow‐up: at minimum 6 months*</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not assessable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; <b>RCT</b> : randomised clinical trial; <b>OIS</b>: optimal information size </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>* Although the trial abstract reported the maximum follow‐up to be two years, it did not specify the time when events occurred for all participants. The trial reported: "All have completed at least six months follow‐up; after the first year the treatment protocol was relaxed to allow fewer variceal band ligation sessions; and 10 have completed the study." 10 children in total seemed to have completed the trial at two‐year follow‐up. </p> <p><sup>1</sup> Downgraded because of: risk of bias (two levels): blinding of participants and personnel (performance bias) was at high risk of bias, and all other domains were at unclear risk of bias; imprecision (two levels): few events; and the CI of the point estimate is very wide and includes both benefit and harm. </p> <p><sup>2</sup>Downgraded because of: risk of bias (two levels): blinding of participants and personnel (performance bias) was at high risk of bias, and all other domains were at unclear risk of bias; imprecision (two levels): the OIS of 2005 participants was not met; few events; and the CI of the point estimate is very wide and includes both benefit and harm. </p> <p><sup>3</sup>Downgraded because of: risk of bias (two levels): blinding of participants and personnel (performance bias) was at high risk of bias, and all other domains were at unclear risk of bias; imprecision (two levels): the OIS of 540 participants was not met; few events; and the CI of the point estimate includes both benefit and harm. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Band ligation compared to sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011561.pub2/full#CD011561-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011561-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Harms reported in observational studies</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Short summary</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Report on harms</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011561-bbs2-0002" title="Celinska-CedroD , TeisseyreM , WoynarowskiM , SochaP , SochaJ , RyzkoJ . Endoscopic ligation of esophageal varices for prophylaxis of first bleeding in children and adolescents with portal hypertension: preliminary results of a prospective study. Journal of Pediatric Surgery2003;38(7):1008-11. [PMID: 12861528]">Celinska‐Cedro 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The study assessed primary prophylaxis with endoscopic variceal ligation in 37 children with portal hypertension (22 with liver cirrhosis and 15 with portal vein thrombosis). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐ No variceal bleeding occurred during the study period.</p> <p>‐ No serious adverse events of variceal ligation were reported.</p> <p>The average follow‐up time was 16 months.</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD011561-bbs2-0004" title="GalandJ , LeyD , CoopmanS , MichaudL , GuimberD , TurckD , et al. Primary prophylaxis of oesophageal variceal bleeding in children by ligation is safe and as efficient as secondary prophylaxis. Journal of Hepatology2018;68(3):600-1. [PMID: 28958884]">Galand 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The study assessed primary prophylaxis of digestive haemorrhage by oesophageal variceal ligation in comparison to secondary prophylaxis. </p> <p>30 children were included in the primary prophylaxis group (median age 7.7 years, range 1.2 to 18 years), and 15 in the secondary prophylaxis group (median age 4.7 years, range 1.5 to 14 years). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐ 2 children had adverse events associated with endoscopic band ligation prophylaxis: <i>Enterobacter cloacae</i> septicaemia (n = 1) and mild transient upper oesophageal sphincter stenosis (n = 1) </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Harms reported in observational studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011561.pub2/full#CD011561-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011561-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Band ligation versus sham or no intervention</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 All‐cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.54 [0.11, 56.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Serious adverse events and liver‐related morbidity <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.1 Idiopathic thrombocytopenic purpura</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.28 [0.01, 6.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.2 Liver transplantation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.54 [0.11, 56.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Oesophageal variceal bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.28 [0.03, 2.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Band ligation versus sham or no intervention</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011561.pub2/references#CD011561-tbl-0003">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD011561.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD011561-note-0006">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD011561-note-0003">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD011561-note-0004">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD011561-note-0005">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD011561-note-0002">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011561\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011561\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011561\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011561\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011561\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011561\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011561\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011561\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011561\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011561\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011561\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011561\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011561\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011561\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011561\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011561\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011561\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011561\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=KUoIaN9D&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011561.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011561.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD011561.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD011561.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011561.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740717131716"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011561.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740717131720"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011561.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918db06f2e68936e',t:'MTc0MDcxNzEzMi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 